If you have a complex health condition that requires specialty medications, our trusted network of specialty pharmacies has resources to help you manage your medications.
Specialty medications are often used to treat certain serious, complex, and chronic health conditions. They're limited to a 30-day supply and may:
Need specialty handling and temperature-controlled storage
Require assistance with administering, such as infusions or injections
Need instructions from your primary care provider (PCP) or other health care providers
Need specialized clinical counseling that standard retail pharmacies are unable to provide
FIND OUT IF YOUR SPECIALTY MEDICATION IS COVERED
This list of specialty medications lets you know which medications are included in your coverage and where to get them filled.
Certain medications are covered only under your pharmacy benefit. To see if your medication is covered, use our Medication Lookup tool.
ABOUT IN-NETWORK SPECIALTY PHARMACIES
Unlike traditional retail pharmacies, specialty pharmacies are experts in supplying specialty medications. They offer valuable services, resources, and convenient access to the care you need, including:
Providing all necessary supplies, at no additional cost, for using specialty medications
Delivering medications to your home or location of your choice
Providing access to nurses and pharmacists who specialize in treating your condition and are available 24/7
Educating you on usage, side effects, administering injections, and more
FIND A SPECIALTY PHARMACY
To get started, have your prescribing provider’s contact information and your member card available. Find which pharmacy can fill your medication on the specialty medication list, then call that in-network specialty pharmacy to fill your order. Your prescribing provider can also send your prescription directly to the specialty pharmacy you choose.
Specialty pharmacy network
Accredo
1-877-988-0058
Fax: 1-800-391-9707 VISIT SITE
Walgreens Specialty Pharmacy 1-888-347-3416 Fax: 1-877-231-8302 VISIT SITE
CVS Specialty 1-866-846-3096 Fax: 1-800-323-2445 VISIT SITE
Fertility medication network
These pharmacies specialize in filling prescriptions for fertility medications.
CVS Specialty 1-866-846-3096 Fax: 1-800-323-2445 VISIT SITE
Freedom Fertility Pharmacy
1-866-297-9452
Fax: 1-888-660-4283 VISIT SITE
Village Fertility Pharmacy Boston (Waltham), MA location only 1-877-334-1610 Fax: 1-877-334-1602 VISIT SITE
Get fit. Lose weight. Gain Savings.
Big congrats on your healthy habits! To celebrate all you do, we’ve put together up to $300 in fitness and weight loss reimbursements. Yours for the taking, you go-getter.
To see how much you're eligible for, sign in to MyBlue.
Get rewarded, no sweat!
Our reimbursement process is quick, easy, and online. Good thing, because look what you can save on:
Health club memberships
Online fitness memberships, subscriptions, programs, or classes
Fitness classes including spin, yoga, and kickboxing
Cardiovascular and strength-training equipment for fitness that is purchased for use in the home, such as stationary bikes, weights, exercise bands, treadmills, fitness machines
In-person or online weight-loss programs like WW (formerly known as Weight Watchers®´´)
Plan coverage may vary. Sign in to MyBlue and check your plan details.
Membership fees at a full-service health club with cardio and strength-training equipment such as treadmills, stationary bikes, weight machines, and free weights.
Fitness class fees at a studio or online with instructor-led group classes such as yoga, Pilates, Zumba®´´, kickboxing, indoor cycling/spinning, and more.
Plan coverage may vary. Sign in to MyBlue and check your plan details.
Participation fees for hospital-based programs and in-person Weight Watchers sessions
Participation fees for Weight Watchers and other non-hospital programs (in-person or online) that combine healthy eating, exercise, and coaching sessions with certified health professionals such as nutritionists, registered dietitians, or exercise physiologists.
Reimbursement for each individual (or family) happens on a per-year basis. You have until March 31 of the following year to submit a request (reimbursement for certain groups may differ).
We'll typically make reimbursement decisions within 30 days of receiving your request. Make sure you keep extra copies of your receipts.
In some cases, reimbursement is considered taxable income – if you have any questions, ask your tax advisor.
Be sure to consult your doctor before starting any exercise or weight loss program.
Electronic Delivery of Communication Related to Your Health Plan Coverage
By clicking here and providing us with an email address and/or mobile phone number, you accept these Terms of Communication and agree to "go paperless" for certain communications about your health plan coverage. This means you are consenting to receive communications electronically via text and/or email instead of by U.S. Mail.
“Health Plan Coverage Electronic Communications” may include:
Notification of available Plan Documents, such as a copy of your evidence of coverage, summary of health plan payments (EOBs), communications regarding complaints, grievances or appeals
Regulatory Notices, including notices of rights under the Women's Health and Cancer Rights Act and state patient protection acts
Notice of Privacy Practices (our Commitment to Confidentiality)
Health-related information, tips, and reminders
Information on understanding and using your Plan
Billing (for members with individual policies, i.e., policies not offered through an employer)
Other documents and information as listed in Communication Preference section of the member portal, such list to be updated from time to time
Blue Cross and Blue Shield of Massachusetts news
The types of communications available electronically are subject to change, and if additional communications become available in an electronic format, you will receive those communications electronically. Occasionally, and as we transition to the new channel of communication, you may also receive a paper document in the mail.
Protected Health Information and Electronic Communications
By agreeing to receive Health Plan Coverage Electronic Communications, you agree to receive messages (including emails, text, and push notifications, to the extent you selected such channels) through an unencrypted method of communication, which means that such information can be at risk of being accessed by third parties during transmission or storage, as the internet is not a secured method of communication. We believe the risks are minimal, and you agree to accept those risks when you agree to these Terms of Communication. Receiving Health Plan Coverage Electronic Communications is an optional service and is not required to receive goods and services from BCBSMA.
You can withdraw your consent to received Health Plan Coverage Electronic Communications at any time by updating your preferences in MyBlue, unsubscribing via the message or text you have received, or calling the Member Service number on your health plan ID card.
The information included in emails and texts may include information related to the payment for and management of your health care, including your protected health information (“PHI”) as defined by the Health Insurance Portability and Accountability Act of 1996, as amended (“HIPAA”).
Your carrier’s message and data rates apply. Message frequency varies and is based on your account settings and plan usage. Reply HELP for help or STOP to cancel.
These Terms of Communication do not affect our practices regarding how we use and disclose PHI, just how we deliver communications to you. To see how we use and disclose PHI, see our Commitment to Confidentiality.
Minor Dependents on My Plan
Unless directed otherwise, we will provide all communications electronically to the email address and mobile number provided by the Subscriber. This means that any information for a minor dependent of the Subscriber will be sent to the Subscriber based on the Subscriber’s selected Communication Preferences.
Getting a Paper Copy of a BCBSMA document
You can print a document yourself, if you have a printer connected to your device.
You have the right to receive a free paper copy of communications that we are required to provide to you. To request a paper copy of a specific communication, call the Member Service phone number on your health plan ID card. Paper delivery of the communication by U.S. Mail will occur within a reasonable time after you request it.
Undeliverable Notices, Updating Your Email Address or Mobile Number
If we attempt to deliver information to an email address you provided and the message is returned as undeliverable after several attempts, we will assume that you have withdrawn your agreement to receive documents electronically. We will begin sending information that we are legally required to send, along with other information that may be available in paper, to you in paper format via U.S. mail. To ensure that you continue to receive emails from us, add the email “from” address to your email address book or safe list to prevent messages from going to your “Junk” folder.
To update your email address or mobile number, log in to MyBlue and go to “Contact Information” under your Profile. If you do not have a MyBlue account, please contact the Member Service number on your health plan ID card.
Deceased Member Affidavit [PDF] A form used for claim reimbursement by the surviving spouse or next of kin of a deceased subscriber.
Direct Pay Application for a Membership Change Pay [PDF] A form to make changes to Direct Pay after a membership change due to circumstances such as marriage, divorce, birth of a child, or loss of eligibility.
Domestic Partnership Affidavit [PDF] When domestic partner coverage is included in your plan, you and your domestic partner must meet certain eligibility criteria. An affidavit is a legal statement that these eligibility requirements are met.
Member’s Designation of an Authorized Representative [PDF] A form designating an individual as your authorized representative, who may discuss and receive information regarding your health care coverage provided through Blue Cross Blue Shield of Massachusetts.
Medicare Advantage Member's Designation of a Personal Representative [PDF] A form for Medicare Advantage members to designate an individual as your authorized representative, who may discuss and receive information regarding your health care coverage provided through Blue Cross Blue Shield of Massachusetts.
Renewal Audit Package [PDF] You and your dependents must live in Massachusetts to renew your individual health plan with Blue Cross Blue Shield of MA. Use this form to show your eligibility.
Student Certificate Affidavit [PDF] A form that certifies that your child is a full-time student at an accredited school. This allows them to continue to be eligible for health coverage under your policy.
Student Medical Leave Affidavit Form [PDF] This form certifies that your student dependent is on a medically necessary leave of absence from a post-secondary school.
Transgender Services [PDF] A form detailing how to request Prior Authorization, or pre-approval, before gender affirming (transgender) services.
Blue Cross Blue Shield Global Core® Brochure [PDF]
An informational guide for Blue Cross members, traveling within the United States or abroad. BlueCard®’ and Blue Cross Blue Shield Global® Core ensure you have access to top doctors and hospitals and concierge-level service.
Open Enrollment Waiver Form [PDF]
If you did not purchase health insurance during open enrollment period, you may request a waiver, visit mass.gov.
When you are billed for services from a provider that does not directly submit a claim to the local Blue Cross Blue Shield plan you may submit that claim for reimbursement.
Eligible members can complete the COVID-19 At-home Test Reimbursement.
International claims form for care received outside of the U.S., Puerto Rico and the U.S. Virgin Islands.
International Claim Form [PDF] A form for members submitting a medical claim when the care is received outside of the U.S., Puerto Rico, and the U.S. Virgin Islands. *Medicare Advantage members please use Medicare Advantage Subscriber Claim Form above.
You may be eligible for reimbursement for certain travel expenses related to obtaining abortion services. To find out if you’re eligible, contact Member Services at 1-888-420-4501.
As a health care organization, we believe strongly that our members should have access to the care they need and want. To support our members in states where abortion access is legally restricted, we are reimbursing certain travel and lodging expenses related to abortion services (either surgical or medication-assisted). See our public statement.
This benefit reimburses you for certain travel and lodging expenses related to obtaining covered services that are not available within 100 miles of your home. To find out if you’re eligible for this benefit, call Member Service at 1-888-420-4501.
Qualifying members will receive tax forms that serve as proof of health insurance coverage.
Form 1099-HC
We'll provide the 2020 Form 1099-HC to qualifying members who were enrolled in a Blue Cross Blue Shield of Massachusetts plan at any time during the calendar year. If you qualify, you'll receive your form:
Via mail, postmarked by January 31, 2021
On their MyBlue account, added on January 31, 2021
To see your Form 1099-HC from the last two years, sign in to MyBlue and, click My Inbox and then Documents. Or you can click directly from here. View My Tax Form.
If you haven't received your 1099-HC by the first week of February, 2021, please call Member Service at the number on the front of your ID card.
Form 1095-B
We'll provide the 2020 Form 1095-B to qualifying members who were enrolled in a Blue Cross Blue Shield of Massachusetts plan at any time during the calendar year. The form will be postmarked by January 31, 2021.
Your Form 1095-B states which months in 2020 you had health care coverage that meets the minimum essential coverage standards set by the federal government under the Affordable Care Act.
You won't receive a Form 1095-B if:
You're a member of a self-funded plan
You're a member with dental-only and/or vision-only plans through Blue Cross
You're enrolled in Medicare Part B or one of our Medicare Advantage plans
You're enrolled in a Health Savings Account plan
You're enrolled in wellness programs that are part of minimum essential coverage
If you haven't received your 1095-B by the first week of February, 2021, please call Member Service at the number on the front of your ID card.
Additional Tax Forms
In addition to Form 1099-HC and Form 1095-B, there are other health care-related tax forms that you won’t receive from Blue Cross. The deadline to provide these forms to qualified members is January 31.
Form 1095-A
Form 1095-A, or the Health Insurance Marketplace Statement, is for people who have health insurance through the Massachusetts Health Connector or an ACA Marketplace plan. This form will be provided to qualified members by their plan.
If you have a health plan through the Massachusetts Health Connector and haven’t received your Form 1095-A by January 31, visit Health Care Connector
Form 1095-C
Form 1095-C is for people who receive health insurance from their employer. This form will be provided to qualified members by their employer.
If you have employer-provided health insurance and haven’t received your Form 1095-C by January 31, please contact your employer or HR department.
Mental Health, Learn to Live
The world feels lighter when you don’t carry it alone
We’re here for every member. Labels don’t apply. Judgment doesn’t exist. Read more to learn about your mental health care options, and how we can help.
Not finding what you need? Call Team Blue at 1-888-389-7764.
Discover options, answers, and understanding
Here's how to get started on finding care that works for you.
If you're facing a life-threatening situation call 911 or go to the nearest emergency room.
Use our Find a Doctor tool to find licensed therapists, counselors, psychiatrists, special facilities, and other resources. Sign in to MyBlue before starting your search, to be sure your results are in our network, and to avoid cost surprises.
Wondering if therapy is right for you? Here's some helpful reading.
I want to talk to a professional
First, if you’re not sure where to start, or how to find the right therapist for you, read our guide.
Next, keep in mind that you can see a licensed therapist online without leaving the comfort and convenience of home.
Use our Find a Doctor tool to find licensed therapists, counselors, psychiatrists, special facilities, and other resources. Sign in to MyBlue before starting your search, to be sure your results are in our network, and to avoid cost surprises.
Your coverage may also include a Well Connection telehealth benefit. Through the Well Connection platform, you'll have access to a licensed therapist or psychiatrist. It’s convenient and confidential. Many plans include Well Connection but some like our Medicare plans, do not. Check your plan benefits for details.
For Medicare HMO Blue and Medicare PPO Blue members: Until further notice, telehealth cost share will be waived for primary care visits, urgently needed visits, health risk assessments and outpatient mental health visits. In addition, cost share will be waived for telehealth visits by a specialist if the visit is related to COVID-19.
I’d prefer to guide myself online
You have two ways to access online programs:
Program Option
Learn to Live®″, Our Online Mental Health Tool
New Directions, Our Assistance and Counseling Program
What it is
Your plan may include access to this judgment-free way to assess and explore your feelings, thoughts, emotions, and mind. Designed by the mental health specialists from Learn to Live, an independent partner company, this tool can be used as often as you like.
All members may now access private online programs and counselors to help manage stress, anxiety, depression, and other conditions, through our partnership with New Directions.
Why members like it
Many people have discovered that this platform can help them manage things like stress, anxiety, depression, and insomnia at their own pace. This program is:
Confidential
Self-guided
No-cost
Available 24/7
Many members find these kinds of programs helpful for working through challenging moments in life, like financial worry or workplace stress.
4. Then, take the 7-minute assessment to get started.
* Don’t see Online Mental Health Tool? Many plans include this tool, but some, like our Medicare plans, do not. Not sure? Call Team Blue at 1-888-389-7764.
Call on Team Blue: 1-888-389-7764. If you can’t find what you need or don’t understand your mental health benefits, we’re ready to help.
How can we help? We're here if you need help finding a therapist or specialist; if you’re not sure what’s covered in your benefits; if you need a hard-to-find specialist; or, if you just don’t know where to start.
Who will you talk to? You’ll start with a dedicated service representative, who will listen to your needs and try to solve your problem. We may then refer you to a Care Manager for specialized support, if needed.
We believe there’s no age limit on mental health. Keep reading for resources to help yourself, your children, and aging family members. See all content.
It’s confidential. Self-guided. No-cost. Available 24/7.
It’s a judgment-free way to assess and explore your feelings, thoughts, emotions and mind. Designed by the behavioral health specialists from Learn to Live®″, an independent partner company, the tool can be used as often as you like — with programs to support:
Social anxiety
Depression
Stress, anxiety, and worry
Insomnia
Substance use
Take the 7-Minute Assessment to get started: sign in to MyBlue, or create an account, then click Online Mental Health Tool under My Plan & Claims.
*Don’t see Online Mental Health Tool? Many plans include this tool, but some, like our Medicare plans, do not. Unsure? Call Team Blue at 1-888-389-7764.
Explore the benefits you have
Sign in to MyBlue or create an account. Click on "My Plans & Benefits." Choose your plan and select "View Plan Benefits." Select a mental health service to view your coverage.
At Blue Cross, our mission is to show up for everyone like they're the only one. This means making sure every member has access to exceptional health care. For our members who identify as lesbian, gay, bisexual, transgender, queer, intersex, asexual, or another sexual orientation (LGBTQIA+), you have high-quality coverage, including gender-affirming care, HIV prevention, reproductive health, fertility preservation, and compassionate support from our team.
Comprehensive Coverage For Our Members
Gender-affirming Care
We offer excellent health coverage, including various types of gender-affirming care, when considered medically necessary.
Get medical care from providers who understand the importance of inclusive health care and the unique needs of LGBTQIA+ individuals and their families.
Help us identify and address health care disparities by providing your sexual orientation and gender identity in MyBlue. This will assist us in achieving more equitable health outcomes for our members.
If you have questions about treatment options or you need support, our trained team is here to help. We have psychiatrists and clinical and mental health experts ready to assist you.
The changes described below apply to members whose plans include pharmacy benefits. To find out which formulary (list of covered medications) your plan uses, sign in to MyBlue.
REMINDER - Effective July 1, 2025, medical policy change for the Blue Cross Blue Shield of Massachusetts formulary
Effective July 1, 2025, we're updating the following medical policy. This change affects our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´ plans1 with a three-tier pharmacy benefit.
For this policy
Update
Immune Modulating Drugs Policy (004)
Humira will be non-covered. Hadlima and Simlandi will continue to be covered as preferred alternatives. Prior authorization will continue to be required.
If Humira is approved through an exception, it will be covered at a higher tier and have a higher copay.
Questions?
If you have any questions, call Team Blue Member Service at the number on your ID card.
1. This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
UPDATE - Effective July 1, 2025, changes to the Blue Cross Blue Shield of Massachusetts formulary and medical policy updates
Effective July 1, 2025, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´ plans* with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Have new quantity or dosing limits
Switch tiers
Require prior authorization and/or step therapy
No longer be covered under the pharmacy benefit and will only be covered under the medical benefit
We’re also making medical policy changes, effective July 1, 2025.
*This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications no longer covered starting July 1, 2025
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
**Members currently taking this medication will be allowed coverage so they can continue using them. They’ll pay the highest copay amount at checkout.
Medications with new quality care dosing limit
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, the medications listed below now require Quality Care Dosing.
Medication class
Medication name
New coverage limit
CNS stimulants
Sodium Oxybate
3 bottles per Rx
Xywav
3 bottles per Rx
Ophthalmic
Xdemvy
1 bottle per Rx
Medications switching tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease.
Medication class
Medication name
2025 Tier
For members with a three-tier pharmacy benefit
For members with a four-tier pharmacy benefit
For members with a five-tier pharmacy benefit
For members with a six-tier pharmacy benefit
CNS stimulants
Wakix
Tier 2a
Tier 3a
Tier 4a
Tier 5a
Xywav
Tier 2b
Tier 3c
Tier 4b
Tier 5c
Growth hormones
Skytrofa
Tier 2c
Tier 3d
Tier 4e
Tier 5f
Sogroya
Tier 2a
Tier 3a
Tier 4a
Tier 5a
a. This medication was previously non-covered. b. This medication was previously covered at Tier 2. c. This medication was previously covered at Tier 3. d. This medication was previously covered at Tier 4. e. This medication was previously covered at Tier 5. f. This medication was previously covered at Tier 6.
Medical policy updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. The policies listed below are being updated. Changes include:
Step therapy policy changes that apply when the medication within the pharmacy medical policy is newly prescribed for members. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
Prior authorization requirements for specific medications to ensure that your prescribing doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For this policy
Update
Immune Modulating Drugs Policy (004)
Humira and the following biosimilars will be moving to non-covered: Adalimumab-AATY, Adalimumab-ADBM, Adalimumab-AACF, Adalimumab-RYVK, Adalimumab-ADAZ, Adalimumab-FKJP.
Hadlima and Simlandi will continue to be covered as preferred alternatives. Prior authorization will continue to be required. If Humira is approved through an exception, it will be covered at a higher tier and have a higher copay.
CNS Stimulants and Psychotherapeutic Agents Policy (019)
This policy will be updated to include Wakix and Xywav as preferred medications. Sodium Oxybate, Lumryz, and Xywav are also being added to this policy.
Prior authorization will be required for new prescriptions.
Medical Benefit Prior Authorization Medication List (034)
(linked to medical policy 033 – Medical Utilization Management (MED UM) & Pharmacy Prior Authorization Policy)
This policy will be updated to reduce approval length of Takhzyro from one year to six months and add continuation criteria.
Drug Management & Retail Pharmacy Prior Authorization Policy (049)
This policy will be updated to include Xdemvy. Prior authorization will be required.
Quality Care Dosing 621b
Policy will be updated to change quantity limits for the following: Sodium Oxybate, Xdemvy, and Xywav.
Quality Care Cancer Program (Medical Oncology) (099)
This policy will be updated to include Alimta, Bendeka, Nplate, Pemetrexed Disodium and Polivy. Prior authorization will be required for new and existing prescriptions, through Carelon Medical Benefits Management.
Immunoglobulins Policy (310)
This policy will be updated to move Hyqvia from preferred to non-preferred.
Drugs for Weight Loss and Cardiovascular Risk Reduction in Overweight and Obesity Policy (572)
To reduce waste, this policy will be updated to include a dispensing limit of 30 days for GLP-1 medications Saxenda, Wegovy, and Zepbound which are used for weight loss.
Looking for more information?
For more information about any of these medications, go to the Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
REMINDER - Effective July 1, 2025, medical policy change for the Blue Cross Blue Shield of Massachusetts formulary
Effective July 1, 2025, we're updating the following medical policy. This change affects our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´ plans1 with a three-tier pharmacy benefit.
For This Policy
Update
Immune Modulating Drugs Policy (004)
Humira will be non-covered. Hadlima and Simlandi will continue to be covered as preferred alternatives. Prior authorization will continue to be required.
If Humira is approved through an exception, it will be covered at a higher tier and have a higher copay.
Questions?
If you have any questions, call Team Blue Member Service at the number on your ID card.
1. This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
PAY SET OUT-OF-POCKET COSTS FOR SELECT MEDICATIONS
Effective on your plan renewal beginning July 1, 2025, members on select plans will pay specific out-of-pocket costs set by the Commonwealth of Massachusetts for select medications that treat the following conditions:
asthma
diabetes (select insulins)
select heart conditions, including congestive heart failure and coronary artery disease
This change is required by a new Massachusetts law and applies to select plans with the Blue Cross Blue Shield of Massachusetts formulary, and the Standard Control with Advanced Control Specialty Formulary.
To find out the cost of your medication, sign in to MyBlue and select Price a Medication under My Medications.
Effective July 1, 2025, changes to the Blue Cross Blue Shield of Massachusetts formulary and medical policy updates
Effective July 1, 2025, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´ plans* with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Be excluded from coverage (exceptions won’t be granted)
Have new quantity or dosing limits
Switch tiers
Require prior authorization and/or step therapy
No longer be covered under the pharmacy benefit and will only be covered under the medical benefit
We’re also making medical policy changes, effective July 1, 2025.
Complete details about these changes will be available by May 27, 2025. Check back at that time.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
*This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
UPDATE - Effective July 1, 2025, medical policy change for the Blue Cross Blue Shield of Massachusetts formulary
Effective July 1, 2025, we're updating the following medical policy. This change affects our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´ plans1 with a three-tier pharmacy benefit.
For This Policy
Update
Immune Modulating Drugs Policy (004)
Humira will be non-covered. Hadlima and Simlandi will continue to be covered as preferred alternatives. Prior authorization will continue to be required.
If Humira is approved through an exception, it will be covered at a higher tier and have a higher copay.
Questions?
If you have any questions, call Team Blue Member Service at the number on your ID card.
1. This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Effective July 1, 2025, medical policy change for the Blue Cross Blue Shield of Massachusetts formulary
Effective July 1, 2025, we're updating a medical policy for our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´1 plans with a three-tier pharmacy benefit.
Complete details about these changes will be available by February 28, 2025. Check back at that time.
Questions?
If you have any questions, call Team Blue Member Service at the number on your ID card.
1. This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
UPDATE - Effective January 1, 2025, Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective January 1, 2025, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´1 plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Be excluded from coverage (exceptions won’t be granted)
Have new quantity or dosing limits
Switch tiers
Require prior authorization and/or step therapy
No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective January 1, 2025.
1. This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications no longer covered starting January 1, 2025
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
1. We’ll continue to cover this medication if you’re already taking it. However, you’ll pay your plan’s highest-tier cost.
Medications excluded from coverage
The following medications will be excluded from our pharmacy benefit as of January 1, 2025. You’ll be responsible for the full cost of these medications when filling a prescription at the pharmacy. This change will apply to all commercial plans, group Medex®´ plans with pharmacy benefits, and Managed Blue for Seniors. Formulary exceptions won’t be accepted for these medications.
Medication Class
Medication Name
Multivitamins
Folivane-F Integra-F
Medications with new quality care dosing (QCD) limits
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, the QCD limit for the below medications has changed.
Medication Class
Medication Name
Previous Coverage Limit
New Coverage Limit
Autoimmune Agents
Skyrizi 150mg/ml
1 syringe per 28 days
1 syringe per 84 days
Skyrizi 180mg/1.2ml
1 syringe per 28 days
1 syringe per 56 days
Skyrizi Pen 150mg/ml
1 pen per 28 days
1 pen per 84 days
Stelara 45mg/0.5ml
1 syringe per 28 days
1 syringe per 84 days
Stelara 45mg/0.5ml
1 vial per 28 days
1 vial per 84 days
Stelara 90mg/ml
2 syringes per 28 days
1 syringe per 56 days
Enbrel 50mg/ml
8 syringes per 28 days
4 syringes per 28 days
Enbrel 50mg/ml Mini
8 syringes per 28 days
4 syringes per 28 days
Enbrel 50mg/ml SureClick
8 syringes per 28 days
4 syringes per 28 days
Taltz 80mg/ml
4 syringes per 28 days
1 syringe per 28 days
Taltz 80mg/ml
4 autoinjectors per 28 days
1 autoinjector per 28 days
Tremfya 100mg/ml
1 syringe per 28 days
1 syringe per 56 days
Tremfya 100mg/ml
1 autoinjector per 28 days
1 autoinjector per 56 days
Medications switching tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease.
Medication Class
Medication Name
2025 Tier
For members with a three-tier pharmacy benefit
For members with a four-tier pharmacy benefit
For members with a five-tier pharmacy benefit
For members with a six-tier pharmacy benefit
Auto-immune agents
Velsipity2
Tier 2a
Tier 3a
Tier 4a
Tier 5a
Antilipemics - PCSK9 Inhibitors
Leqvio2
Tier 3b
Tier 4c
Tier 3b
Tier 4c
Central Nervous System - Antipsychotics (long acting)
Abilify Asimtufii
Tier 2a
Tier 3a
Tier 2a
Tier 3a
Gastrointestinal - Irritable Bowel Syndrom
Viberzi2
Tier 2a
Tier 3a
Tier 2a
Tier 3a
Immunologic Agents
Infliximab2
Tier 3b
Tier 4c
Tier 5d
Tier 6e
2. This medication also requires prior authorization.
This medication was previously non-covered.
This medication was previously covered at Tier 2.
This medication was previously covered at Tier 3.
This medication was previously covered at Tier 4.
This medication was previously covered at Tier 5.
This medication was previously covered at Tier 6.
Medications requiring prior authorization
For certain medications, your doctor must first obtain approval before we cover them. The following medication now requires prior authorization:
Medication Name
Viberzi3
3. If you’re currently filling prescriptions for this medication, you won’t need prior authorization.
Medical policy updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. The policies listed below are being updated. Changes include:
Step therapy policy changes that apply when the medication within the pharmacy medical policy is newly prescribed for members. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
Prior authorization requirements for specific medications to ensure that your prescribing doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For This Policy
Update
Immune Modulating Drugs Policy (004)
Velsipity will move from the “Non-Formulary, Non-Preferred Drugs” section to the “Formulary Non-Preferred Drugs” section for the treatment of Ulcerative Colitis.
Medical Benefit Prior Authorization Medication List (034)
(linked to medical Policy 033 – Medical Utilization Management (MED UM) & Pharmacy Prior Authorization Policy)
This policy will be updated to include Cuvitru, Jesduvroq, and Spevigo. Prior authorization will be required for new and existing prescriptions to be covered under the medical benefit.
This policy will be updated to include Adlyxin, Bydureon, Byetta, Liraglutide, Mounjaro, Ozempic, Saxenda, Soliqua, Tanzeum, Trulicity, Victoza, Wegovy, Xultophy, and Zepbound. Starting January 1, 2025, these medications will only be covered through the pharmacy benefit. Coverage through the medical benefit will end December 31, 2024.
Supportive Care Treatments for Patients with Cancer (105)
This policy will be updated to include Udenyca, Udenyca On Body, and Fulphila. These medications will be required to be used prior to the approval of Neulasta, Neulasta On Pro, and Ziextenzo.
Immunoglobulins Policy (310)
This policy will be updated to include Cutaquig and Hizentra. These medications will be required to be used prior to the approval of Cuvitru.
Quality Care Dosing (621B)
Policy will be updated to change quantity limits of following immunologic agents: Enbrel, Skyrizi, Stelara, Taltz, and Tremfya.
Looking for more information?
For more information about any of these medications, go to the Medication Lookup tool.
Questions?
If you have any questions, contact your account executive.
Effective January 1, 2025, Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective January 1, 2025, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Be excluded from coverage (exceptions won’t be granted)
Have new quantity or dosing limits
Switch tiers
Require prior authorization and/or step therapy
No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective January 1, 2025.
Complete details about these changes will be available by October 31, 2024 at bluecrossma.org/pharmacy_updates under the Blue Cross Formulary tab.
Questions? If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
*This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Changes to Our Specialty Pharmacy Network for Fertility Medications
On December 1, 2024, Encompass Fertility®´, a subsidiary of CVS Pharmacy that administers specialty fertility medications, will be leaving our specialty pharmacy network. At this time, CVS SpecialtyTM will be joining our specialty pharmacy network to administer specialty fertility medications for our members.
If you currently fill your medication through Encompass Fertility, CVS Specialty will contact you by December 1, 2024 to help you transition to CVS Specialty.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the Standard Control with Advanced Control Specialty Formulary. For more information, visit our specialty medications resource page.
Questions?
If you have any questions, call Team Blue Member Service at the number on your ID card.
UPDATE - Effective January 1, 2025, Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective January 1, 2025, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´1 plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Be excluded from coverage (exceptions won’t be granted)
Have new quantity or dosing limits
Switch tiers
Require prior authorization and/or step therapy
No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective January 1, 2025.
1. This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications no longer covered starting January 1, 2025
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
1. We’ll continue to cover this medication if you’re already taking it. However, you’ll pay your plan’s highest-tier cost.
Medications excluded from coverage
The following medications will be excluded from our pharmacy benefit as of January 1, 2025. You’ll be responsible for the full cost of these medications when filling a prescription at the pharmacy. This change will apply to all commercial plans, group Medex®´ plans with pharmacy benefits, and Managed Blue for Seniors. Formulary exceptions won’t be accepted for these medications.
Medication Class
Medication Name
Multivitamins
Folivane-F Integra-F
Medications with new quality care dosing (QCD) limits
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, the QCD limit for the below medications has changed.
Medication Class
Medication Name
Previous Coverage Limit
New Coverage Limit
Autoimmune Agents
Skyrizi 150mg/ml
1 syringe per 28 days
1 syringe per 84 days
Skyrizi 180mg/1.2ml
1 syringe per 28 days
1 syringe per 56 days
Skyrizi Pen 150mg/ml
1 pen per 28 days
1 pen per 84 days
Stelara 45mg/0.5ml
1 syringe per 28 days
1 syringe per 84 days
Stelara 45mg/0.5ml
1 vial per 28 days
1 vial per 84 days
Stelara 90mg/ml
2 syringes per 28 days
1 syringe per 56 days
Enbrel 50mg/ml
8 syringes per 28 days
4 syringes per 28 days
Enbrel 50mg/ml Mini
8 syringes per 28 days
4 syringes per 28 days
Enbrel 50mg/ml SureClick
8 syringes per 28 days
4 syringes per 28 days
Taltz 80mg/ml
4 syringes per 28 days
1 syringe per 28 days
Taltz 80mg/ml
4 autoinjectors per 28 days
1 autoinjector per 28 days
Tremfya 100mg/ml
1 syringe per 28 days
1 syringe per 56 days
Tremfya 100mg/ml
1 autoinjector per 28 days
1 autoinjector per 56 days
Medications switching tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease.
Medication Class
Medication Name
2025 Tier
For members with a three-tier pharmacy benefit
For members with a four-tier pharmacy benefit
For members with a five-tier pharmacy benefit
For members with a six-tier pharmacy benefit
Auto-immune agents
Velsipity2
Tier 2a
Tier 3a
Tier 4a
Tier 5a
Antilipemics - PCSK9 Inhibitors
Leqvio2
Tier 3b
Tier 4c
Tier 3b
Tier 4c
Central Nervous System - Antipsychotics (long acting)
Abilify Asimtufii
Tier 2a
Tier 3a
Tier 2a
Tier 3a
Gastrointestinal - Irritable Bowel Syndrom
Viberzi2
Tier 2a
Tier 3a
Tier 2a
Tier 3a
Immunologic Agents
Infliximab2
Tier 3b
Tier 4c
Tier 5d
Tier 6e
2. This medication also requires prior authorization.
This medication was previously non-covered.
This medication was previously covered at Tier 2.
This medication was previously covered at Tier 3.
This medication was previously covered at Tier 4.
This medication was previously covered at Tier 5.
This medication was previously covered at Tier 6.
Medications requiring prior authorization
For certain medications, your doctor must first obtain approval before we cover them. The following medication now requires prior authorization:
Medication Name
Viberzi3
3. If you’re currently filling prescriptions for this medication, you won’t need prior authorization.
Medical policy updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. The policies listed below are being updated. Changes include:
Step therapy policy changes that apply when the medication within the pharmacy medical policy is newly prescribed for members. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
Prior authorization requirements for specific medications to ensure that your prescribing doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For This Policy
Update
Immune Modulating Drugs Policy (004)
Velsipity will move from the “Non-Formulary, Non-Preferred Drugs” section to the “Formulary Non-Preferred Drugs” section for the treatment of Ulcerative Colitis.
Medical Benefit Prior Authorization Medication List (034)
(linked to medical Policy 033 – Medical Utilization Management (MED UM) & Pharmacy Prior Authorization Policy)
This policy will be updated to include Cuvitru, Jesduvroq, and Spevigo. Prior authorization will be required for new and existing prescriptions to be covered under the medical benefit.
This policy will be updated to include Adlyxin, Bydureon, Byetta, Liraglutide, Mounjaro, Ozempic, Saxenda, Soliqua, Tanzeum, Trulicity, Victoza, Wegovy, Xultophy, and Zepbound. Starting January 1, 2025, these medications will only be covered through the pharmacy benefit. Coverage through the medical benefit will end December 31, 2024.
Supportive Care Treatments for Patients with Cancer (105)
This policy will be updated to include Udenyca, Udenyca On Body, and Fulphila. These medications will be required to be used prior to the approval of Neulasta, Neulasta On Pro, and Ziextenzo.
Immunoglobulins Policy (310)
This policy will be updated to include Cutaquig and Hizentra. These medications will be required to be used prior to the approval of Cuvitru.
Quality Care Dosing (621B)
Policy will be updated to change quantity limits of following immunologic agents: Enbrel, Skyrizi, Stelara, Taltz, and Tremfya.
Looking for more information?
For more information about any of these medications, go to the Medication Lookup tool.
Questions?
If you have any questions, contact your account executive.
Effective January 1, 2025, Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective January 1, 2025, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Be excluded from coverage (exceptions won’t be granted)
Have new quantity or dosing limits
Switch tiers
Require prior authorization and/or step therapy
No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective January 1, 2025.
Complete details about these changes will be available by October 31, 2024 at bluecrossma.org/pharmacy_updates under the Blue Cross Formulary tab.
Questions? If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
*This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Effective May 15, 2024, Select Diabetes and Weight-Loss Medications No Longer Available Through the Mail Service Pharmacy
Effective May 15, 2024, due to a medication shortage, you won’t be able to fill the following diabetes and weight-loss medications in 90-day supplies through the mail service pharmacy:
Diabetes Medications
Weight-Loss Medications
• Mounjaro • Trulicity
• Wegovy • Saxenda
These medications will continue to be available in 30-day supplies through in-network retail pharmacies. If you fill these medications through the mail service pharmacy, you should have received a letter from CVS Customer Care with more information about the change.
If you want to find an in-network pharmacy that’s convenient to you, sign in to MyBlue, then select Find a Pharmacy under My Medications. You can also call Team Blue Member Service at the number on your ID card.
Questions?
If you have any questions, call CVS Customer Care at 1-877-817-0477 (TTY: 711).
On August 1, 2024, AllianceRx Walgreens Specialty Pharmacy will become Walgreens Specialty Pharmacy
AllianceRx Walgreens Specialty Pharmacy delivers specialty pharmacy services to individuals with complex medical conditions. On August 1, 2024, they’re changing their name to Walgreens Specialty Pharmacy. You don’t need to take any action if you’re currently using this pharmacy. They’ll continue to fill your covered prescriptions — just under a new name.
To reach Walgreens Specialty Pharmacy:
Phone: 1-888-347-3416
Fax: 1-877-231-8302
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
Acaria Health Is Leaving Our Specialty Pharmacy Network
On July 1, 2024, Acaria Health will be leaving our specialty pharmacy network.
If you fill your prescriptions through Acaria Health, you can complete your current course of treatment with Acaria Health, but treatments starting on or after July 1, 2024 will need to be filled through through Accredo, AllianceRx Walgreens Pharmacy, or CVS Specialty in order to be covered. If you’re currently using Acaria Health, you should have received a letter from us about next steps.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the Standard Control with Advanced Control Specialty Formulary. For more information about specialty medications, use our Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
UPDATE - Effective July 1, 2024, Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective July 1, 2024, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Require prior authorization and/or step therapy
We’re also making medical policy changes, effective July 1, 2024.
*This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications No Longer Covered Starting July 1, 2024
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
*If you’re currently taking any of these medications, you’ll be allowed coverage so you can continue using them. You’ll pay the highest copay amount at checkout.
Medications Switching Tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease.
Medication Class
Medication Name
2024 Tier
For members with a three-tier pharmacy benefit
For members with a four-tier pharmacy benefit
For members with a five-tier pharmacy benefit
For members with a six-tier pharmacy benefit
Anti-migraine
Qulipta
Tier 2a
Tier 3a
Tier 2a
Tier 3a
Zavzpret
Tier 3b
Tier 4c
Tier 3b
Tier 4c
Auto-immune agents
Kevzara
Tier 3b
Tier 4c
Tier 5d
Tier 6e
Hepatitis C treatments
ledipasvir/sofosbuvir
sofosbuvir/velpatasvir
Tier 2a
Tier 3a
Tier 4a
Tier 5a
Women’s health
Myfembree
Orilissa
Tier 2a
Tier 3a
Tier 2a
Tier 3a
a. This medication was previously non-covered.
b. This medication was previously covered at Tier 2.
c. This medication was previously covered at Tier 3.
d. This medication was previously covered at Tier 4.
e. This medication was previously covered at Tier 5.
f. This medication was previously covered at Tier 6.
Medical Policy Updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. The policies listed below are being updated. Changes include:
Step therapy policy changes that apply when the medication within the pharmacy medical policy is newly prescribed for members. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
Prior authorization requirements for specific medications to ensure that your doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For This Policy
Update
Botulinum Toxin Injections (006)
Adding Daxxify, Myobloc, and Xeomin as non-covered medications.
Immunomodulators for Skin Conditions Policy (010)
Adding Adbry and Cibinqo as non-covered medications.
Updating Rinvoq’s medical necessity criteria for coverage. For members 12 years or older with moderate-to-severe atopic dermatitis (eczema), we’ll cover the medication when they’ve had an inadequate response to trying a corticosteroid and calcineurin inhibitor.
Anti-Migraine Policy (021)
Qulipta is moving from non-covered to preferred and requires the use of two covered alternatives before approval. This will apply to members newly prescribed these medications.
Updating Dupixent’s medical necessity criteria for coverage. For members six months or older with moderate-to-severe atopic dermatitis (eczema), we’ll cover the medication when they’ve had an inadequate response to trying a corticosteroid and calcineurin inhibitor.
Phosphodiesterase Type-5 Inhibitors for Pulmonary Arterial Hypertension (036)
This policy will be retired on July 1, 2024.
Benign Prostatic Hyperplasia (040)
This policy will be retired on July 1, 2024.
Supportive Care Treatments for Patients with Cancer (105)
Adding Fulphila, Fylnetra, Nivestym, Nyvepria, Releuko, Rolvedon, Stimufend, and Udenyca as non-covered medications.
Hepatitis C Medication Management (344)
Adding Vosevi as a non-covered medication and Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir as covered medications.
Topical Ocular Hydrating Agents Policy (426)
Prior authorization will be required for new prescriptions of Lacrisert to treat dry eye disease.
Looking for More Information?
For more information about any of these medications, go to our Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
Effective July 1, 2024, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective July 1, 2024, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Be excluded from coverage (exceptions won’t be granted)
Switch tiers
Require prior authorization and/or step therapy
No longer be covered under the pharmacy benefit and will only be covered under the medical benefit
We’re also making medical policy changes, effective July 1, 2024.
Complete details about these changes will be available by May 31, 2024. Check back at that time.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
*This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
UPDATE: Effective April 1, 2024, Upcoming Medical Policy Change for the Blue Cross Blue Shield of Massachusetts Formulary
Effective April 1, 2024, we're updating the following medical policy to provide coverage for more affordable medication options. This change affects our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´1 plans with a three-tier pharmacy benefit.
For This Policy
Update
Immune Modulating Drugs Policy (004)
Remicade will be non-covered. Inflectra and Avsola will continue to be covered as preferred alternatives and Renflexis and Infliximab as non-preferred alternatives. Prior authorization will continue to be required.
Amjevita will be non-covered. Humira, Hadlima, and Yusimry will continue to be covered as preferred alternatives and Adalimumab-adbm, Adalimumab-adaz, Adalimumab-fkjp, and Hyrimoz (Cordavis product) will be covered as non-preferred alternatives. If Amjevita is approved through an exception, it will be covered at a higher tier and have a higher copay. Prior authorization will continue to be required.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
1. This doesn’t include Medex®´2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Effective April 1, 2024, Upcoming Medical Policy Change for the Blue Cross Blue Shield of Massachusetts Formulary
Effective April 1, 2024, we're updating a medical policy for our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´1 plans with a three-tier pharmacy benefit.
Complete details about these changes will be available by January 11, 2024. Check back at that time.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
1. This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Some Previously Announced Medical Policy Changes for the Blue Cross Blue Shield of Massachusetts Formulary Are Being Delayed
The medical policy changes below, which were previously announced to be effective January 1, 2024, are being delayed to March 1, 2024.
For This Policy
Update
Immune Modulating Drugs Policy (004)
Dosing and frequency of use will be required as part of prior authorization for the following medications: Actemra (non-preferred), Avsola (preferred), Orencia (non-preferred), Inflectra (preferred), Infliximab (non-preferred), Remicade (non-preferred), Renflexis (non-preferred). These medications are covered under the pharmacy benefit, and the medical benefit for providers that signed the medical benefit amendment to buy and bill.
Injectable Asthma Medications (017)
Dosing and frequency of use will be required as part of prior authorization for Xolair in order to be covered under the medical benefit.
Dosing and frequency of use will be required as part of prior authorization for the following medications in order for them to be covered under the medical benefit: Prolia, Tepezza, Xgeva.
Dosing and frequency of use will be required as part of prior authorization for Aflibercept (Eylea) in order to be covered under the medical benefit.
Soliris, Ultomiris, Myasthenia Gravis, and Neuromyelitis Optica Policy (093)
Dosing and frequency of use will be required as part of prior authorization for Soliris in order to be covered under the medical benefit.
Nononcologic Uses of Rituximab (123)
Dosing and frequency of use will be required as part of prior authorization for the following medications in order for them to be covered under the medical benefit: Riabni, Rituxan, Ruxience, Truxima.
Entyvio (Vedolizumab) Policy (162)
Dosing and frequency of use will be required as part of prior authorization for Entyvio in order to be covered under the medical benefit.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
AllianceRx Walgreens Pharmacy Will Join Our Specialty Pharmacy Network
On January 1, 2024, AllianceRx Walgreens Pharmacy will join our specialty pharmacy network. Specialty pharmacies provide medications that are used to treat certain complex health conditions. For more information about specialty medications, use our Medication Lookup tool.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts Formulary, and the Standard Control with Advanced Control Specialty Formulary.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
UPDATE - Effective January 1, 2024, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective January 1, 2024, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´1 plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Have new quantity or dosing limits
Be required to be filled at an in-network specialty pharmacy
Require prior authorization and/or step therapy
No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective January 1, 2024.
1. This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications No Longer Covered Starting January 1, 2024
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class
Medication Name
Covered Alternative
Antibiotics
Doxycycline Hyclate 75 mg and 150 mg
Doxycycline 50 mg and 100 mg
Bisphosphonates
Actonel
Risedronate
Continuous Glucose Monitors*
Enlite Eversense Guardian
Dexcom Freestyle Libre
Iron Reducers
Exjade Jadenu
Deferasirox
Ferriprox
Deferiprone
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)*
Indocin suspension
Naproxen suspension
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Diclofenac 25 mg capsules
Diclofenac 50 mg
Diclofenac 2% suspension
Diclofenac 1.5%
Ketoprofen 200 mg ER
Ketoprofen
Meloxicam Submicronized
Meloxicam
Oral Corticosteroids*
Prednisolone 5 mg
Prednisone
Steroid Inhalers
Flovent Diskus Flovent HFA
Fluticasone Propionate
Steroid Combination Inhalers
Symbicort
Breyna
Topical Antimicrobials
Noritate
Metronidazole
Topical Antifungal - Onychomycosis
Tavaborole
Ciclopirox
Tyrosine Metabolism Inhibitor
Orfadin
Nitisinone
Urinary Retention Agents
Uroxatral
Alfuzosin ER
*If you’re currently using these medications, you’ll be allowed to continue and will pay your highest copay amount.
Medications with New Quality Care Dosing (QCD) Limit
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, the medication listed below now requires QCD.
Medication Class
Medication Name
New Coverage Limit
COVID-19 treatment
Paxlovid
One (1) carton per fill (enough to treat per FDA), and one (1) fill for 5 days every 30 days
Medications Required to Be Filled at an In-Network Specialty Pharmacy
Effective January 1, 2024, the following medications will only be covered when filled at an in-network specialty pharmacy:
Acetadote
Dichlorphenamide
Lynparza
Synarel
Arcalyst
Emflaza
Lytgobi
Tazicef
Asparlas
Estradiol Valerate
Marqibo
Testosterone Enanthate
Bicillin L-A
Evomela
Mektovi
Tiopronin
Braftovi
Fortaz
Mugard
Tlando
Calquence
Gavreto
Nitisinone
Uptravi
Carglumic Acid
Inbrija
Nityr
Ventavis
Cometriq
Ingrezza
Onpattro
Veozah
Cutaquig
Ingrezza Initiation Pack
Portrazza
Vincasar PFS
Cystaran
Jatenzo
Qutenza
Vyepti
Daraprim
Jayvygtor
Reblozyl
Vyxeos
Deferoxamine Mesylate
Jynarque
Rimso-50
Yondelis
Delestrogen
Kanuma
Rolvedon
Yonsa
Depo-Estradiol
Koselugo
Romidepsin
Zejula
Desferal Mesylate
Kyzatrex
Sajazir
Zydelig
Prior Authorization Now Required for Briumvi and Ocrevus
Effective January 1, 2024, prior authorization will be required for new and existing prescriptions of Briumvi and Ocrevus in order to be covered by your plan.
The medications will be covered under our medical benefit when administered at a health care provider’s office, by a home health care provider, by a home infusion therapy provider, or in an outpatient hospital and dialysis setting. They’ll be covered under our pharmacy benefit when they’re filled at a specialty pharmacy.
Prior authorization won’t be required when Briumvi and Ocrevus are administered in inpatient, surgical day care, urgent care centers or emergency department settings.
Coverage Changes for Certain Medications Being Removed from Our Medical Benefit
Effective January 1, 2024, the following specialty medications will no longer be covered by our medical benefit. They’ll only be covered under our pharmacy benefit when filled at an in-network specialty pharmacy. Prior authorization is still required for these medications. This change will apply to all medical plans, except Medicare Advantage, Medical Supplemental plans, and Federal Employee Program plans.
Simponi Aria
Stelara
If you’re currently filling these specialty medications at an in-network specialty pharmacy under our pharmacy benefit, you won’t experience a break in coverage. If you’re currently filling these medications under our medical benefit and have pharmacy coverage with Blue Cross Blue Shield of Massachusetts, you’ll receive a detailed letter about the coverage change, along with next steps. If you don’t have pharmacy coverage from Blue Cross Blue Shield of Massachusetts, we’ll also send you a letter about the change, with additional information about contacting your prescription plan to find out if you’re covered for these medications.
Medical Policy Updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. The policies listed below are being updated. Changes include:
Step therapy policy changes that apply when the medication within the pharmacy medical policy is newly prescribed for members. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
Prior authorization requirements for specific medications to ensure your doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For This Policy
Update
Immune Modulating Drugs Policy (004)
This policy will be updated to reflect the removal of medical benefit coverage for Simponi Aria and Stelara mentioned above.
Dosing and frequency of use will be required as part of prior authorization for the following medications: Actemra (non-preferred), Avsola (preferred), Orencia (non-preferred), Inflectra (preferred), Infliximab (non-preferred), Remicade (non-preferred), Renflexis (non-preferred). These medications are covered under the pharmacy benefit, and the medical benefit for providers that signed the medical benefit amendment to buy and bill.
Injectable Asthma Medications (017)
Dosing and frequency of use will be required as part of prior authorization for Xolair in order to be covered under the medical benefit.
This medical policy will be updated to include Briumvi and Ocrevus. Prior authorization will be required for new and existing prescriptions to be covered under the medical or pharmacy benefit.
Tysabri currently requires prior authorization under the medical benefit and will require prior authorization under the pharmacy benefit, effective January 1, 2024.
Dosing and frequency of use will be required as part of prior authorization for the following medications in order for them to be covered under the medical benefit: Prolia, Tepezza, Xgeva.
Bisphosphonates, Oral (058)
This policy will be retired on January 1, 2024.
Injectable Specialty Medication Coverage (071)
This policy will be updated to include Simponi Aria and Stelara.
This policy will be updated to remove Alymsys, MVASI, Vegzelma and Zirabev.
This policy is changing to a prior authorization policy and all Step 2 and Step 3 medications under this policy will transition from a step therapy to a prior authorization requirement. Prior authorization will be required for new prescription for any medication under this policy.
Soliris, Ultomiris, Myasthenia Gravis, and Neuromyelitis Optica Policy (093)
Dosing and frequency of use will be required as part of prior authorization for Soliris in order to be covered under the medical benefit.
Quality Care Cancer Program (Medical Oncology) (099)
Riabni will move from preferred to non-preferred and Truxima will move from non-preferred to preferred for new prescriptions. Prior authorization through Carelon Medical Benefit Management, as part of the Quality Care Cancer Program, will continue to be required.
Supportive Care Treatments for Patients with Cancer (105)
Fulphila will move from preferred to non-preferred for new prescriptions.
Nononcologic Uses of Rituximab (123)
Dosing and frequency of use will be required as part of prior authorization for the following medications in order for them to be covered under the medical benefit: Riabni, Rituxan, Ruxience, Truxima.
Entyvio (Vedolizumab) Policy (162)
Dosing and frequency of use will be required as part of prior authorization for Entyvio in order to be covered under the medical benefit.
Prior authorization will be required for new prescriptions of Kesimpta.
The following medications will no longer require step therapy but will require prior authorization to be covered. This applies to new prescriptions for these medications: Avonex, Betaseron, Extavia, Plegridy, Rebif.
Looking for More Information?
For more information about any of these medications, go to the Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Effective January 1, 2024, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective January 1, 2024, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Have new quantity or dosing limits
Require prior authorization and/or step therapy
No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective January 1, 2024.
Complete details about these changes will be available by October 31, 2023. Check back at that time.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
*This doesn’t include Medex®´2 plans with Blue MedicareRxTM (PDP) prescription drug coverage.
Some Previously Announced Medical Policy Changes for the Blue Cross Blue Shield of Massachusetts Formulary Are Being Delayed
The medical policy changes below, which were previously announced to be effective January 1, 2024, are being delayed to March 1, 2024.
For This Policy
Update
Immune Modulating Drugs Policy (004)
Dosing and frequency of use will be required as part of prior authorization for the following medications: Actemra (non-preferred), Avsola (preferred), Orencia (non-preferred), Inflectra (preferred), Infliximab (non-preferred), Remicade (non-preferred), Renflexis (non-preferred). These medications are covered under the pharmacy benefit, and the medical benefit for providers that signed the medical benefit amendment to buy and bill.
Injectable Asthma Medications (017)
Dosing and frequency of use will be required as part of prior authorization for Xolair in order to be covered under the medical benefit.
Dosing and frequency of use will be required as part of prior authorization for the following medications in order for them to be covered under the medical benefit: Prolia, Tepezza, Xgeva.
Dosing and frequency of use will be required as part of prior authorization for Aflibercept (Eylea) in order to be covered under the medical benefit.
Soliris, Ultomiris, Myasthenia Gravis, and Neuromyelitis Optica Policy (093)
Dosing and frequency of use will be required as part of prior authorization for Soliris in order to be covered under the medical benefit.
Nononcologic Uses of Rituximab (123)
Dosing and frequency of use will be required as part of prior authorization for the following medications in order for them to be covered under the medical benefit: Riabni, Rituxan, Ruxience, Truxima.
Entyvio (Vedolizumab) Policy (162)
Dosing and frequency of use will be required as part of prior authorization for Entyvio in order to be covered under the medical benefit.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
UPDATE - Effective January 1, 2024, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective January 1, 2024, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´1 plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Have new quantity or dosing limits
Be required to be filled at an in-network specialty pharmacy
Require prior authorization and/or step therapy
No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective January 1, 2024.
1. This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications No Longer Covered Starting January 1, 2024
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class
Medication Name
Covered Alternative
Antibiotics
Doxycycline Hyclate 75 mg and 150 mg
Doxycycline 50 mg and 100 mg
Bisphosphonates
Actonel
Risedronate
Continuous Glucose Monitors*
Enlite Eversense Guardian
Dexcom Freestyle Libre
Iron Reducers
Exjade Jadenu
Deferasirox
Ferriprox
Deferiprone
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)*
Indocin suspension
Naproxen suspension
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Diclofenac 25 mg capsules
Diclofenac 50 mg
Diclofenac 2% suspension
Diclofenac 1.5%
Ketoprofen 200 mg ER
Ketoprofen
Meloxicam Submicronized
Meloxicam
Oral Corticosteroids*
Prednisolone 5 mg
Prednisone
Steroid Inhalers
Flovent Diskus Flovent HFA
Fluticasone Propionate
Steroid Combination Inhalers
Symbicort
Breyna
Topical Antimicrobials
Noritate
Metronidazole
Topical Antifungal - Onychomycosis
Tavaborole
Ciclopirox
Tyrosine Metabolism Inhibitor
Orfadin
Nitisinone
Urinary Retention Agents
Uroxatral
Alfuzosin ER
*If you’re currently using these medications, you’ll be allowed to continue and will pay your highest copay amount.
Medications with New Quality Care Dosing (QCD) Limit
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, the medication listed below now requires QCD.
Medication Class
Medication Name
New Coverage Limit
COVID-19 treatment
Paxlovid
One (1) carton per fill (enough to treat per FDA), and one (1) fill for 5 days every 30 days
Medications Required to Be Filled at an In-Network Specialty Pharmacy
Effective January 1, 2024, the following medications will only be covered when filled at an in-network specialty pharmacy:
Acetadote
Dichlorphenamide
Lynparza
Synarel
Arcalyst
Emflaza
Lytgobi
Tazicef
Asparlas
Estradiol Valerate
Marqibo
Testosterone Enanthate
Bicillin L-A
Evomela
Mektovi
Tiopronin
Braftovi
Fortaz
Mugard
Tlando
Calquence
Gavreto
Nitisinone
Uptravi
Carglumic Acid
Inbrija
Nityr
Ventavis
Cometriq
Ingrezza
Onpattro
Veozah
Cutaquig
Ingrezza Initiation Pack
Portrazza
Vincasar PFS
Cystaran
Jatenzo
Qutenza
Vyepti
Daraprim
Jayvygtor
Reblozyl
Vyxeos
Deferoxamine Mesylate
Jynarque
Rimso-50
Yondelis
Delestrogen
Kanuma
Rolvedon
Yonsa
Depo-Estradiol
Koselugo
Romidepsin
Zejula
Desferal Mesylate
Kyzatrex
Sajazir
Zydelig
Prior Authorization Now Required for Briumvi and Ocrevus
Effective January 1, 2024, prior authorization will be required for new and existing prescriptions of Briumvi and Ocrevus in order to be covered by your plan.
The medications will be covered under our medical benefit when administered at a health care provider’s office, by a home health care provider, by a home infusion therapy provider, or in an outpatient hospital and dialysis setting. They’ll be covered under our pharmacy benefit when they’re filled at a specialty pharmacy.
Prior authorization won’t be required when Briumvi and Ocrevus are administered in inpatient, surgical day care, urgent care centers or emergency department settings.
Coverage Changes for Certain Medications Being Removed from Our Medical Benefit
Effective January 1, 2024, the following specialty medications will no longer be covered by our medical benefit. They’ll only be covered under our pharmacy benefit when filled at an in-network specialty pharmacy. Prior authorization is still required for these medications. This change will apply to all medical plans, except Medicare Advantage, Medical Supplemental plans, and Federal Employee Program plans.
Simponi Aria
Stelara
If you’re currently filling these specialty medications at an in-network specialty pharmacy under our pharmacy benefit, you won’t experience a break in coverage. If you’re currently filling these medications under our medical benefit and have pharmacy coverage with Blue Cross Blue Shield of Massachusetts, you’ll receive a detailed letter about the coverage change, along with next steps. If you don’t have pharmacy coverage from Blue Cross Blue Shield of Massachusetts, we’ll also send you a letter about the change, with additional information about contacting your prescription plan to find out if you’re covered for these medications.
Medical Policy Updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. The policies listed below are being updated. Changes include:
Step therapy policy changes that apply when the medication within the pharmacy medical policy is newly prescribed for members. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
Prior authorization requirements for specific medications to ensure your doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For This Policy
Update
Immune Modulating Drugs Policy (004)
This policy will be updated to reflect the removal of medical benefit coverage for Simponi Aria and Stelara mentioned above.
Dosing and frequency of use will be required as part of prior authorization for the following medications: Actemra (non-preferred), Avsola (preferred), Orencia (non-preferred), Inflectra (preferred), Infliximab (non-preferred), Remicade (non-preferred), Renflexis (non-preferred). These medications are covered under the pharmacy benefit, and the medical benefit for providers that signed the medical benefit amendment to buy and bill.
Injectable Asthma Medications (017)
Dosing and frequency of use will be required as part of prior authorization for Xolair in order to be covered under the medical benefit.
This medical policy will be updated to include Briumvi and Ocrevus. Prior authorization will be required for new and existing prescriptions to be covered under the medical or pharmacy benefit.
Tysabri currently requires prior authorization under the medical benefit and will require prior authorization under the pharmacy benefit, effective January 1, 2024.
Dosing and frequency of use will be required as part of prior authorization for the following medications in order for them to be covered under the medical benefit: Prolia, Tepezza, Xgeva.
Bisphosphonates, Oral (058)
This policy will be retired on January 1, 2024.
Injectable Specialty Medication Coverage (071)
This policy will be updated to include Simponi Aria and Stelara.
This policy will be updated to remove Alymsys, MVASI, Vegzelma and Zirabev.
This policy is changing to a prior authorization policy and all Step 2 and Step 3 medications under this policy will transition from a step therapy to a prior authorization requirement. Prior authorization will be required for new prescription for any medication under this policy.
Soliris, Ultomiris, Myasthenia Gravis, and Neuromyelitis Optica Policy (093)
Dosing and frequency of use will be required as part of prior authorization for Soliris in order to be covered under the medical benefit.
Quality Care Cancer Program (Medical Oncology) (099)
Riabni will move from preferred to non-preferred and Truxima will move from non-preferred to preferred for new prescriptions. Prior authorization through Carelon Medical Benefit Management, as part of the Quality Care Cancer Program, will continue to be required.
Supportive Care Treatments for Patients with Cancer (105)
Fulphila will move from preferred to non-preferred for new prescriptions.
Nononcologic Uses of Rituximab (123)
Dosing and frequency of use will be required as part of prior authorization for the following medications in order for them to be covered under the medical benefit: Riabni, Rituxan, Ruxience, Truxima.
Entyvio (Vedolizumab) Policy (162)
Dosing and frequency of use will be required as part of prior authorization for Entyvio in order to be covered under the medical benefit.
Prior authorization will be required for new prescriptions of Kesimpta.
The following medications will no longer require step therapy but will require prior authorization to be covered. This applies to new prescriptions for these medications: Avonex, Betaseron, Extavia, Plegridy, Rebif.
Looking for More Information?
For more information about any of these medications, go to the Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Effective January 1, 2024, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective January 1, 2024, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Have new quantity or dosing limits
Require prior authorization and/or step therapy
No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective January 1, 2024.
Complete details about these changes will be available by October 31, 2023. Check back at that time.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
*This doesn’t include Medex®´2 plans with Blue MedicareRxTM (PDP) prescription drug coverage.
UPDATE - Effective July 1, 2023, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective July 1, 2023, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´1 plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Have new quantity or dosing limits
Switch tiers
Require prior authorization and/or step therapy
No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective July 1, 2023.
1. This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications No Longer Covered Starting July 1, 2023
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Atabex EC
Atabex OB
Azesco
Bal-Care DHA
C-Nate DHA
CitraNatal
CitraNatal 90 DHA
CitraNatal Assure
CitraNatal B-Calm
CitraNatal Bloom
CitraNatal DHA
CitraNatal Harmony
Complete Natal DHA pak
CompleteNate chew
Co-natal FA
Concept DHA
Concept OB
Duet DHA 400 mis 25-1-400
Duet DHA Balanced
EnBrace HR
Folivane-OB cap
Jenliva
Koshr prenatal tab 30-1mg
M-Natal Plus tab
Multi-Mac tab
Mynatal tab
Mynatal tab advance
Mynate 90 tab plus
Natachew chew
Natalvit tab 75-1mg
NeevoDHA
Neonatal Complete
Neonatal Complete tab
Neonatal DHA
Neonatal FE tab
Neonatal Plus
Neonatal Plus tab 27-1mg
Nestabs tab
Nestabs DHA pak
Nestabs one cap
Niva-plus
OB Complete/cap DHA
OB Complete one
OB Complete petite
OB Complete tab
OB Complete tab premier
Obstetrix One cap 38-1-225
Obstetrix DHA pak
Obstetrix EC tab
O-Cal tab prenatal
One Vite plus
PNV-DHA cap docusate
PNV-omega cap
PNV tabs tab 29-1mg
PR Natal 400 pak
PR Natal EC 400 pak
Pregen DHA cap
Pregenna tab
Premesis Rx tab
Prena1 chew
Prena1 Pearl cap
Prena1 True
Prenaissance cap
Prenaissance Plus cap
Prenara cap prenatal
Prenatal 19 chew 29-1mg
Prenatal+FE tab 29-1mg
Prenatal tab 27-1mg
Prenatal vitamin tab low iron
Prenate
Prenate AM tab 1mg
Prenate chew 0.6-0.4
Prenate DHA
Prenate Elite tab
Prenate Enhance cap
Prenate Essential
Prenate Mini
Prenate Restore cap
Prenatal-u cap 106.5-1
Prenatal tab 27-1mg
Prenatal tab plus
Prenatvite Complete tab
Prenatvite Plus tab
Prenatvite Rx tab
Preplus tab 27-1mg
Pretab tab 29-1mg
Primacare cap
Provida OB cap
R-natal OB cap 20-1-320
Redichew Rx chew
Relnate DHA cap
Se-Natal 19 tab
Se-Natal 19 chew
Select-OB chew
Select-OB+DHA pak
Taron-C DHA cap
Taron-Prex cap
Thrivite Rx tab 29-1mg
TriCare prenatal
Trinatal Rx tab 1
Tri-Tabs DHA mis
TriStart DHA
TriStart Free cap
TriStart One cap 35-1-215
Triveen-duo pak DHA
Vinate One tab
Vinate II tab
Vinate DHA cap 27-1.13
Vitatrue mis
Virt-Nate cap DHA
Virt-PN Plus cap
Vitafol chew gummies
Vitafol FE+cap
Vitafol-Nano
Vitafol-Nano tab
Vitafol-OB
Vitafol-OB pak +DHA
Vitafol-One cap
Vitafol Ultra
vitaMedMD One Rx
Vitapearl
Vitathely
Virt-C DHA cap
Virt-PN DHA cap
Viva DHA cap
Vol-Plus
Vol-Tab Rx tab
VP-PNV-DHA cap
Wescap-C DHA cap
Wescap-PN DHA cap
Wesnate DHA cap
Westab Plus tab 27-1mg
Westgel DHA cap
Zalvit tab 13-1mg
Zatean-PN DHA cap
Zatean-PN Plus cap
Ziphex
Elite OB tab
Inatal GT tab
Prenatabs Rx tab
Prenatal 19 chew tab
PNV-DHA cap
PNV-Select tab
Trinate tab
Medications with New Quality Care Dosing (QCD) Limit
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, the medication listed below now requires Quality Care Dosing (QCD).
Medication Class
Medication Name
New Coverage Limit
Tetracycline Antibiotic
Nuzyra 150 mg Tablet ONLY
30 tablets per 30 days
Medications Switching Tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower tier under certain pharmacy plans, and what you pay for the following medications may decrease.
Medication Class
Medication Name
2023 Tier for members with a three-tier pharmacy benefit
2023 Tier for members with a four-tier pharmacy benefit
2023 Tier for members with a five-tier pharmacy benefit
2023 Tier for members with a six-tier pharmacy benefit
Monoclonal Antibodies
Nucala2
Tier 2a
Tier 3b
Tier 4c
Tier 5d
Xolair2
Tier 2a
Tier 3b
Tier 4c
Tier 5d
2. This medication also has prior authorization and/or step therapy requirements.
a. This medication was previously covered at Tier 3.
b. This medication was previously covered at Tier 4.
c. This medication was previously covered at Tier 5.
d. This medication was previously covered at Tier 6.
Coverage Changes for Certain Medications Moving from Our Medical to Pharmacy Benefit
Effective July 1, 2023, coverage for the following specialty medications will move out of our medical benefit and only be included under our pharmacy benefit. These medications will also only be covered when filled at an in-network specialty pharmacy. This change will apply to all medical plans, except Medicare Advantage, Medical Supplemental plans, and Federal Employee Program plans.
Ilumya
Skyrizi
If you’re currently filling these specialty medications at an in-network specialty pharmacy under your pharmacy benefit, you won’t experience a break in coverage as these medications move from the medical benefit to the pharmacy benefit. If you’re currently filling these medications under your medical benefit and have pharmacy coverage with Blue Cross Blue Shield of Massachusetts, you’ll receive a detailed letter about the coverage change, along with next steps. If you don’t have pharmacy coverage from Blue Cross Blue Shield of Massachusetts, we’ll also send you a letter about the change, with additional information about contacting your prescription plan to find out if you’re covered for these medications.
Medical Policy Updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. The policies listed below are being updated. Changes include:
Step therapy policy changes that apply when the medication within the pharmacy medical policy is newly prescribed for members. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
Prior authorization requirements for specific medications to ensure your doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For this policy
Update
Immune Modulating Drugs Policy (004)
This policy will be updated to reflect the medical to pharmacy benefit coverage change for Ilumya and Skyrizi as noted below in the Injectable Specialty Medication Coverage Policy (071).
Immunomodulators for Skin Conditions Policy (010)
Rinvoq coverage criteria will be updated to require the use of another systemic medication other than Dupixent, before it’s covered.
The Drug-Systemic step table in this policy will be updated from a three-step to a two-step and will require the use of two Step 1 medications prior to a Step 2 medication being approved. As a result, Cibinqo will move from Step 3 to Step 2 with in this policy. This will apply to you if these medications are newly prescribed.
Injectable Asthma Medications Policy (017)
A prescription by a specialist will no longer be required in order for Xolair to be covered. Prior authorization will be required for new prescriptions.
Ilumya and Skyrizi will be added to this policy. These medications will be covered only under the pharmacy benefit starting July 1, 2023 and prior authorization will be required for new prescriptions.
Step therapy requirements will be updated to require the use of a steroid and tacrolimus or pimecrolimus, before covering Dupixent (when used to treat atopic dermatitis, also known as eczema).
Looking for More Information?
For more information about any of these medications, go to the Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Quality Care Dosing Limits Have Increased for Select Medications
To give doctors greater flexibility when prescribing certain controlled substances, we’ve doubled the quality care dosing limit for the medications listed below. The change took effect on April 12, 2023, and applies to members whose plans have pharmacy coverage through Blue Cross Blue Shield of Massachusetts and use the Blue Cross formulary.
The following medications increased coverage to 60 units for a 30-day supply:
AMPHETAMINE/DEXTROAMPHETAMINE CAP 5MG ER
AMPHETAMINE/DEXTROAMPHETAMINE CAP 10MG ER
AMPHETAMINE/DEXTROAMPHETAMINE CAP 15MG ER
AMPHETAMINE/DEXTROAMPHETAMINE CAP 25MG ER
METHYLPHENIDATE TAB 18MG ER
METHYLPHENIDATE TAB 27MG ER
METHYLPHENIDATE TAB 54MG ER
The following medications increased coverage to 120 units for a 30-day supply:
AMPHETAMINE/DEXTROAMPHETAMINE CAP 20MG ER
AMPHETAMINE/DEXTROAMPHETAMINE CAP 30MG ER
METHYLPHENIDATE TAB 36MG ER
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Effective July 1, 2023, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective July 1, 2023, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Be excluded from coverage (exceptions won’t be granted)
Switch tiers
Require prior authorization and/or step therapy
No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective July 1, 2023.
Complete details about these changes will be available by May 31, 2023. Check back at that time.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
*This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Effective January 1, 2023, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary
Effective January 1, 2023, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Be excluded from coverage (exceptions won’t be granted)
Switch tiers
Require prior authorization and/or step therapy
*This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications No Longer Covered Starting January 1, 2023
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class
Medication Name
Covered Alternative
Antidiabetic —
Dipeptidyl Peptidase-4 (DPP4) Enzyme Inhibitor and Combinations
This medication also has prior authorization and/or step therapy requirements.
If you currently use this medication, you’ll continue to be covered until your prior authorization expires.
If you use this medication, you’ll experience a copay increase as of January 1, 2023.
Medications Excluded from Coverage
Certain medications will be excluded from our pharmacy benefit, effective January 1, 2023. You’ll be responsible for the full cost of these medications when filling a prescription at the pharmacy. This change will apply to all commercial plans, group Medex®´plans with pharmacy benefits, and Managed Blue for Seniors. Formulary exceptions won’t be accepted for these medications. We’ll contact you if you’ll be affected by this change.
To find out if a medication is excluded from coverage, effective January 1, 2023, use the Medication Lookup tool.
Medications Switching Tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease. This isn’t a complete list of medications switching tiers, and we’ll contact you if you’ll be affected by this change.
To find out which tier a medication is in, effective January 1, 2023, use the Medication Lookup tool.
Medication Class
Medication Name
2023 Tier for members with a three-tier pharmacy benefit
2023 Tier for members with a four-tier pharmacy benefit
2023 Tier for members with a five-tier pharmacy benefit
2023 Tier for members with a six-tier pharmacy benefit
* This medication also has prior authorization and/or step therapy requirements.
This medication was previously covered at Tier 3.
This medication was previously covered at Tier 4.
This medication was previously covered at Tier 5.
This medication was previously covered at Tier 6.
This medication was previously non-covered.
Medical Policy Updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. We’re updating the policies listed below. These changes include:
Step therapy policy changes that apply when the medication within the pharmacy medical policies is newly prescribed for you. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
Prior authorization requirements for specific medications to ensure your doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For this policy
Update
Anti-Migraine Policy (021)
Qulipta and Vyepti are moving from covered to non-covered. Prior authorization requirements will still apply. If you currently use these medications, you’ll continue to be covered until your prior authorization expires.
The prescription lookback period for step therapy is changing for the following medications: Aimovig, Ajovy, and Emgality. This applies to you if these medications have been newly prescribed.
Diabetes Step Therapy (041)
Bydureon, Bydureon BCise, Byetta, Kombiglyze XR, and Onglyza are moving from covered to non-covered. As a result, these medications will move from Step 2 to Step 3 within this policy. If you currently use these medications, or if they’re newly prescribed, new prior authorization is required.
Ozempic, Rybelsus, and Victoza are moving from non-covered to covered. As a result, these medications will move from Step 3 to Step 2 within this policy.
Immune Modulating Medications(004)
All medications in this policy will move from indication-based prior authorization to non-indication-based prior authorization. Preferred medications must be used before non-preferred medications will be approved and covered.
Actemra, Actemra ACTPen, Cimzia, Ilumya, Kineret, Olumiant, Orencia, Orencia ClickJect, Siliq, and Simponi are moving from covered to non-covered. If you currently use these medications, you’ll continue to be covered until your prior authorization expires. Some members currently using these medications will experience an increase in out-of-pocket costs. If these medications are newly prescribed for you, prior authorization is required.
Drug Management and Retail Pharmacy Prior Authorization Policy (049)
Xifaxan will move from non-covered to covered. Prior authorization requirements will be required to check against Food and Drug Administration requirements. If you currently use these medications, you’ll continue to be covered until your prior authorization expires.
Multiple Sclerosis Step Therapy (839)
Prior authorization will be required for the following medications, to check against Food and Drug Administration requirements: Aubagio, Gilenya, Mavenclad, Mayzent, Vumerity, and Zeposia.
Looking for More Information?
For more information about any of these medications, use the Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Effective January 1, 2023, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary
Effective January 1, 2023, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Be excluded from coverage (exceptions won’t be granted)
Switch tiers
Require prior authorization and/or step therapy
*This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications No Longer Covered Starting January 1, 2023
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class
Medication Name
Covered Alternative
Antidiabetic —
Dipeptidyl Peptidase-4 (DPP4) Enzyme Inhibitor and Combinations
This medication also has prior authorization and/or step therapy requirements.
If you currently use this medication, you’ll continue to be covered until your prior authorization expires.
If you use this medication, you’ll experience a copay increase as of January 1, 2023.
Medications Excluded from Coverage
Certain medications will be excluded from our pharmacy benefit, effective January 1, 2023. You’ll be responsible for the full cost of these medications when filling a prescription at the pharmacy. This change will apply to all commercial plans, group Medex®´plans with pharmacy benefits, and Managed Blue for Seniors. Formulary exceptions won’t be accepted for these medications. We’ll contact you if you’ll be affected by this change.
To find out if a medication is excluded from coverage, effective January 1, 2023, use the Medication Lookup tool.
Medications Switching Tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease. This isn’t a complete list of medications switching tiers, and we’ll contact you if you’ll be affected by this change.
To find out which tier a medication is in, effective January 1, 2023, use the Medication Lookup tool.
Medication Class
Medication Name
2023 Tier for members with a three-tier pharmacy benefit
2023 Tier for members with a four-tier pharmacy benefit
2023 Tier for members with a five-tier pharmacy benefit
2023 Tier for members with a six-tier pharmacy benefit
* This medication also has prior authorization and/or step therapy requirements.
This medication was previously covered at Tier 3.
This medication was previously covered at Tier 4.
This medication was previously covered at Tier 5.
This medication was previously covered at Tier 6.
This medication was previously non-covered.
Medical Policy Updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. We’re updating the policies listed below. These changes include:
Step therapy policy changes that apply when the medication within the pharmacy medical policies is newly prescribed for you. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
Prior authorization requirements for specific medications to ensure your doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For this policy
Update
Anti-Migraine Policy (021)
Qulipta and Vyepti are moving from covered to non-covered. Prior authorization requirements will still apply. If you currently use these medications, you’ll continue to be covered until your prior authorization expires.
The prescription lookback period for step therapy is changing for the following medications: Aimovig, Ajovy, and Emgality. This applies to you if these medications have been newly prescribed.
Diabetes Step Therapy (041)
Bydureon, Bydureon BCise, Byetta, Kombiglyze XR, and Onglyza are moving from covered to non-covered. As a result, these medications will move from Step 2 to Step 3 within this policy. If you currently use these medications, or if they’re newly prescribed, new prior authorization is required.
Ozempic, Rybelsus, and Victoza are moving from non-covered to covered. As a result, these medications will move from Step 3 to Step 2 within this policy.
Immune Modulating Medications (004)
All medications in this policy will move from indication-based prior authorization to non-indication-based prior authorization. Preferred medications must be used before non-preferred medications will be approved and covered.
Actemra, Actemra ACTPen, Cimzia, Ilumya, Kineret, Olumiant, Orencia, Orencia ClickJect, Siliq, and Simponi are moving from covered to non-covered. If you currently use these medications, you’ll continue to be covered until your prior authorization expires. Some members currently using these medications will experience an increase in out-of-pocket costs. If these medications are newly prescribed for you, prior authorization is required.
Drug Management and Retail Pharmacy Prior Authorization Policy (049)
Xifaxan will move from non-covered to covered. Prior authorization requirements will be required to check against Food and Drug Administration requirements. If you currently use these medications, you’ll continue to be covered until your prior authorization expires.
Multiple Sclerosis Step Therapy (839)
Prior authorization will be required for the following medications, to check against Food and Drug Administration requirements: Aubagio, Gilenya, Mavenclad, Mayzent, Vumerity, and Zeposia.
Looking for More Information?
For more information about any of these medications, use the Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Encompass Fertility™ Has Joined Our Specialty Pharmacy Network for Fertility Medications
Effective July 19, 2022, Encompass Fertility has joined our specialty pharmacy network for fertility medications. They have access to all our covered fertility medications, and they can fill and ship medications in all 50 states.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the National Preferred Formulary (NPF). For more information about specialty fertility medications, use our Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Metro Drugs Is Leaving Our Specialty Pharmacy Network for Fertility Medications
Effective May 1, 2022, Metro Drugs, a fertility medication pharmacy, will be leaving our specialty pharmacy network. If you’re taking fertility medications and fill your prescriptions through Metro Drugs, you’ll be able to complete your current course of treatment with Metro Drugs, but treatments starting after May 1, 2022 will need to be filled through Freedom Fertility Pharmacy, or Village Fertility Pharmacy in order to be covered. If you’re currently using Metro Drugs, you’ll receive a letter from us about next steps.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the National Preferred Formulary (NPF). For more information about specialty fertility medications, use our Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Pharmacy Medical Policy Updates
Effective July 1, 2022, we’re updating the Blue Cross Blue Shield of Massachusetts formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´ plans with a three-tier pharmacy benefit.* As part of the formulary update, certain medications are switching tiers.
We’ve also discontinued a medical policy as of March 1, 2022, and we’re making additional medical policy changes on April 1, 2022 and July 1, 2022.
*This doesn’t include Medex 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications Switching Tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease.
Medication Class
Medication Name
2022 Tier for members with a three-tier pharmacy benefit
2022 Tier for members with a four-tier pharmacy benefit
2022 Tier for members with a five-tier pharmacy benefit
2022 Tier for members with a six-tier pharmacy benefit
Inflammatory Conditions
Avsola
Tier 2a
Tier 3b
Tier 4c
Tier 5d
Neulasta
Tier 2a
Tier 3b
Tier 4c
Tier 5d
Ziextenzo
Tier 2a
Tier 3b
Tier 4c
Tier 5d
This medication was previously covered at Tier 3.
This medication was previously covered at Tier 4.
This medication was previously covered at Tier 5.
This medication was previously covered at Tier 6.
Pharmacy Medical Policy Updates
Pharmacy medical policies are evidence-based documents that we develop to define the technologies, procedures, and treatments that are considered medically necessary; not medically necessary; and investigational. We use pharmacy medical policies to describe how we cover certain medications. We’re updating the following policies:
Policies
Update
Date of Change
Dificid (fidaxomicin) (700)
This step therapy policy has been discontinued.
We no longer require members to have prior treatment or failure with vancomycin before covering Dificid (fidaxomicin).
Members who have an approved exception to cover Dificid (fidaxomicin) don’t need their doctors to renew this request.
3/1/2022
Immune Modulating Drugs (004)
Avsola will move from non-preferred to preferred within the Remicade and infliximab biosimilars policy section.
Inflectra and Avsola will now be the preferred medications in this policy.
4/1/2022
Quality Care Cancer Program (Medical Oncology) (099)
Nononcologic Uses of Rituximab (123)
Riabni will move from non-preferred to preferred. Truxima will move from preferred to non-preferred.
Ruxience and Riabni will now be the preferred medications in these policies.
Members currently using Truxima will have continued coverage so their care isn’t disrupted.
7/1/2022
Quality Care Cancer Program (Medical Oncology) (099)
Herzuma, Ogivri, and Ontruzant will move from preferred to non-preferred.
Kanjinti and Trazimera continue to be the preferred medications in this policy.
Members currently using Herzuma, Ogivri, or Ontruzant will have continued coverage so their care isn’t disrupted.
Providers who request prior authorization for Herzuma, Ogivri, and Ontruzant will need to go through AIM Specialty Health.
Supportive Care Treatments for Patients with Cancer (105)
Udenyca will move from preferred to non-preferred.
Neulasta and Ziextenzo will move from non-preferred to preferred.
Fulphila, Neulasta, and Ziextenzo will now be the preferred medications listed in these policies.
Members currently using Udenyca will have continued coverage so their care isn’t disrupted.
7/1/2022
Learn More About Medications
Use the Medication Lookup tool to learn more about coverage for these medications.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary, Effective January 1, 2022
Beginning January 1, 2022, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´ * plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
*This doesn’t include Medex 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications No Longer Covered Starting January 1, 2022
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you'll pay the highest-tier cost.
*This medication also has prior authorization and/or step therapy requirements.
Medications Switching Tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease.
Medication Class
Medication Name
2022 Tier for members with a three-tier pharmacy benefit
2022 Tier for members with a four-tier pharmacy benefit
2022 Tier for members with a five-tier pharmacy benefit
2022 Tier for members with a six-tier pharmacy benefit
Inflammatory Conditions
Avsola*
Tier 3b
Tier 4c
Tier 5d
Tier 6e
Cimzia*
Tier 3g
Tier 4g
Tier 5g
Tier 6g
Orencia*
Tier 3g
Tier 4g
Tier 5g
Tier 6g
Orencia Clickjet*
Tier 3g
Tier 4g
Tier 5g
Tier 6g
Siliq*
Tier 3g
Tier 4g
Tier 5g
Tier 6g
Simponi*
Tier 3g
Tier 4g
Tier 5g
Tier 6g
Simponi Aria*
Tier 3g
Tier 4g
Tier 5g
Tier 6g
Bowel Evacuants
Plenvu
Tier 3g
Tier 4g
Tier 3g
Tier 4g
Diabetes – SGLT2/DPP4 Inhibitor Combinations
Trijardy XR*
Tier 2c
Tier 3d
Tier 2c
Tier 3d
Inhaled Combination Agents
Breztri*
Trelegy Ellipta*
Tier 2g
Tier 3g
Tier 2g
Tier 3g
Methotrexate Autoinjectors
Otrexup*
Tier 3g
Tier 4g
Tier 5g
Tier 6g
Methotrexate Autoinjectors
Rasuvo*
Tier 3g
Tier 4g
Tier 3g
Tier 4g
*This medication also has prior authorization and/or step therapy requirements.
This medication was previously covered at Tier 1.
This medication was previously covered at Tier 2.
This medication was previously covered at Tier 3.
This medication was previously covered at Tier 4.
This medication was previously covered at Tier 5.
This medication was previously covered at Tier 6.
This medication was previously non-covered.
Medications with New Quality Care Dosing Limits
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, some of the medications listed below now require Quality Care Dosing (QCD), while the QCD limit has changed for others.
Medication Class
Medication Name
Quality Care Dosing Limit
per prescription
Anti-Parasite Treatment
Alinia 500 mg tablets
Nitazoxanide 500 mg tablets
6 tablets
Alinia 100 mg/5 mL suspension
180 mL
Antineoplastic Medications
Jakafi 5 mg, 10 mg, 15 mg, 20 mg, 25 mg tablets
60
Pomalyst 1 mg, 2 mg, 3 mg, 4 mg capsules
21
Cabometyx 20 mg, 40 mg, 60 mg tablets
30
Tagrisso 40 mg, 80 mg tablets
30
Verzenio 50 mg, 100 mg, 150 mg, 200 mg tablets
60
Tardive Dyskinesia Treatment
Ingrezza 40 mg-80 mg initiation pack
1 pack
Ingrezza 40 mg, 60 mg, 80 mg capsules
30
Medical Policy Updates
Medical policies are evidence-based documents that Blue Cross develops to define the technologies, procedures, and treatments that are considered medically necessary, not medically necessary, and investigational. We use Pharmacy medical policies to describe how we cover certain medications. We’re updating the policies listed below. These changes include:
Step therapy policy changes that apply when the medication within the pharmacy medical policies is newly prescribed for you. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
Prior authorization. This applies if you are newly prescribed Alunbrig.
For this policy
Update
Anti-Migraine Policy (021)
Adding dihydroergotamine spray and Migranal spray to step 3 for acute migraine treatment. This will apply to members newly prescribed these medications.
Asthma and Chronic Obstructive Pulmonary Disease Medication Management (011)
Adding Trelegy Ellipta and Breztri as step 2 agents requiring the use of other covered products for Asthma/Chronic Obstructive Pulmonary Disease (COPD) to be used prior to approval. This will apply to members newly prescribed these medications.
Diabetes Step Therapy (041)
Moving Trijardy XR from step 3 to step 2 under the DPP4 and SGLT2 sections of the policy. Members with a claim history or an approved authorization don’t need to do anything, but these medications will now be covered at a lower-tier cost. New prescriptions for this medication will follow the step therapy policy.
Immune Modulating Drugs (004)
Adding Zeposia to non-preferred and requiring the use of two preferred agents prior to approval (when used to treat ulcerative colitis [UC]). This will apply to members newly prescribed these medications.
Injectable Methotrexate
(Otrexup & Rasuvo) (840)
New medical policy that requires the use of generic methotrexate before we’ll approve coverage of either Otrexup or Rasuvo. Applies to new prescriptions.
Multiple Sclerosis Step Therapy (839)
New medical policy that requires the use of dimethyl fumarate or glatiramer/Glatopa before we’ll cover other agents. Applies to new prescriptions.
Oncology Drugs (409)
Requiring prior authorization for Alunbrig. Applies to new prescriptions.
Looking for More Information?
For more information about any of these medications, use the Medication Lookup tool at bluecrossma.org/medication.
Questions?
If you have any questions, please call Member Service at the number on the front of your ID card.
Effective July 1, 2021, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary
Beginning July 1, 2021, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´ plans* with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Have new quantity or dosing limits
Require prior authorization
*This doesn’t include Medex 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications No Longer Covered Starting July 1, 2021
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if these medications are medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
**The covered alternatives for Narcotic Analgesics will be added to our formulary on April 1, 2021.
Medications with New Quality Care Dosing Limits
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, some of the medications listed below now require Quality Care Dosing (QCD), while the QCD limit has changed for others.
For certain medications, your doctor must first obtain approval before we cover them. The following medications now require prior authorization:
Medication Class
Fulphila
Granix
Nivestym
Riabni
Ruxience
Truxima
Udenyca
Zarxio
Ziextenzo
Looking for More Information?
For more information about any of these medications, use the Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
Effective July 1, 2021, New Opioid Safety Review to Be Implemented at Pharmacies
Effective July 1, 2021, pharmacists filling an opioid prescription will be alerted if you may be receiving a total level of opioids that’s potentially unsafe. This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, as well as Medex®’ plans* with a three-tier pharmacy benefit and Managed Blue for Seniors plans.
Under this safety review, when a pharmacist is filling an opioid prescription, they’ll receive a real-time alert if your total opioid dose across all opioid or opioid-containing prescriptions reaches or exceeds 90 morphine milligram equivalents (MME) per day. If the pharmacist determines the opioid dose is appropriate for care, they can fill the prescription. However, if they believe there could be a safety issue, they may choose not to fill the prescription.
If the pharmacist doesn’t fill the prescription, your prescribing doctor can contact Blue Cross to request authorization for coverage. If authorized, coverage will be approved for up to one year. However, one of the following must be true for the request to be approved:
The member has a diagnosis of cancer.
The member is receiving opioids as part of palliative care.
The prescriber says that the amount of opioid prescribed is necessary for adequate pain management, based on the member’s clinical circumstances.
This safety review doesn’t apply to prescriptions written by in-network oncologists, palliative care providers, and pain management specialists.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
*This doesn’t include Medex 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Upcoming Coverage Changes for Certain Medications Moving from Our Medical to Pharmacy Benefit
Effective July 1, 2021, coverage for the following medications will move out of our medical benefit and only be included under our pharmacy benefit. This change will apply to all medical plans, except Managed Blue for Seniors, group Medicare Advantage, group Medex®´, and Federal Employee Program plans.
Medications Moving from Our Medical to Pharmacy Benefit
Available at Retail Pharmacies
Durolane*
Gel-One*
GelSyn-3*
Monovisc*
Triluron*
Trivisc*
Must Be Filled at a Specialty Pharmacy
Bynfezia
Cosentyx*
Dupixent*
Fasenra*
Kevzara*
Nucala*
Siliq*
Strensiq
Tegsedi*
Tremfya*
Members who have plans with the Blue Cross Blue Shield of Massachusetts formulary, as well as Medex®’ plans** with a three-tier pharmacy benefit, or the National Preferred Formulary*** will receive coverage for these medications under their pharmacy benefit upon the effective date. Members with these plans will not experience a break in coverage as these medications move from the medical benefit to the pharmacy benefit. Group Medex plans with a three-tier pharmacy benefit will include coverage for these medications under both the medical and pharmacy benefit. If you don’t have pharmacy coverage from Blue Cross Blue Shield of Massachusetts, refer to your pharmacy plan benefit materials for coverage details on these medications.
If affected, we’ll contact you about this change and help you transition your prescription to support uninterrupted coverage.
This change doesn’t apply when these medications are administered in inpatient, surgical day care, ambulatory surgery center, and emergency department settings.
Questions?
For more information, call Team Blue at the Member Service number on your ID card.
*These medications require prior authorization.
**This doesn’t include Medex 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
***Plans with the National Preferred Formulary may have additional coverage requirements for these medications.
Coverage for Certain Infused Oncology Medications Moving to the Medical Benefit
Effective July 1, 2021, the infused oncology medications listed below will only be covered under our medical benefit through the Quality Care Cancer Program and will require prior authorization. These medications will no longer be included in our pharmacy benefit.
Oncology Medications That Will Be Covered Under Our Medical Benefit
Abraxane
Herceptin
Onivyde
Arzerra
Herceptin Hylecta
Ontruzant
Bavencio
Herzuma
Opdivo
Cyramza
Imfinzi
Poteligeo
Doxil/Lipodox
Kanjinti
Proleukin
Empliciti
Keytruda
Rituxan-Hycela
Fusilev
Khapzory
Tecentriq
Gazyva
Ogivri
Trazimera
The Quality Care Cancer Program, which launches July 1, 2021, is administered by AIM Specialty Health®´´ (AIM), an independent company. You can learn more about this program, which helps ensure the cancer treatments we cover are safe and appropriate for our members, here.
This change only applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, as well as Medex®´ plans* with a three-tier pharmacy benefit. This change doesn’t apply to group Medicare Advantage and Federal Employee Program plans. If you’re a member of an affected plan and are currently filling these medications under the pharmacy benefit, you’ll be able to complete your treatment course without interruption.
If your plan includes medical benefits from Blue Cross and pharmacy benefits from another carrier, you can receive coverage for these medications from us under your medical benefit. To see if you’re also covered by your pharmacy benefits from another carrier, please refer to your pharmacy plan benefit materials.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
*This doesn’t include Medex 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Upcoming Changes to Opioid Coverage
We’re making several changes to our coverage of opioids, a class of medication that’s sometimes prescribed by doctors and providers to treat pain. Effective April 1, 2021, we’ll cover Xtampza ER. With this change, we’ll no longer cover OxyContin and Oxycodone ER, the authorized generic, as of July 1, 2021. We’ll work with prescribers to transition members to Xtampza ER, the covered alternative, when clinically appropriate. Prescribers will need to request prior authorization for Xtampza ER.
If a member needs to continue taking OxyContin or Oxycodone ER, their prescriber may request an exception if the medication is medically necessary. If the exception is approved, the member will pay the highest-tier cost.
Prescribers without Prior Authorization Must Request It before July 1, 2021
To support the safe and appropriate use of opioids, we’re expanding our Pain Management Policy. With the expansion, prescribers who don’t have an approved authorization for coverage of a member’s opioid medication must request authorization for that member’s medication before July 1, 2021. We’ll then review the request to determine if the medication is medically necessary. Prescribers who’ve already received prior authorization for a member’s opioid medication don’t need to request it again until it expires. Oncologists, palliative care providers, and pain management specialists in the Blue Cross Blue Shield of Massachusetts network are exempt from this prior authorization requirement. We’ll notify you and your prescriber if this change applies to you.
If you have any questions, please call Member Service on the front of your ID card.
Updates to the Blue Cross Blue Shield of Massachusetts Formulary Changes, Effective January 1, 2021
We previously announced changes to the Blue Cross Blue Shield of Massachusetts formulary (list of covered medications) that are going into effect January 1, 2021. Since then, we’ve made updates to these formulary changes. The updates are as follows:
Medications No Longer Covered Starting January 1, 2021
The non-covered and covered alternatives for high-triglyceride treatments and muscle relaxants are changing. Chlorzoxazone 250 mg will no longer be a covered alternative to specific Lorzone medications and will remain non-covered. The correct medications and covered alternatives are listed below:
Medications in the high-triglyceride treatment class listed below will move to a higher cost tier, so what you pay for the following medications may increase.
Medication Class
Medication Name
2021 Tier for members with a three-tier pharmacy benefit
2021 Tier for members with a four-tier pharmacy benefit
2021 Tier for members with a five-tier pharmacy benefit
2021 Tier for members with a six-tier pharmacy benefit
High-triglyceride treatments
fenofibrate 40 mg, 43 mg, 120 mg, and 130 mg
Tier 2a
Tier 3b
Tier 2a
Tier 3b
a. This medication was previously covered at Tier 1.
b. This medication was previously covered at Tier 2.
Medications with New Quality Care Dosing Limits
Quality Care Dosing helps us ensure that the quantity and dose of certain prescription medications meet the Food and Drug Administration, manufacturer, and clinical recommendations. Two additional medications will have Quality Care Dosing limits:
Medication Class
Medication Name
Quality Care Dosing Limit
per Prescription
Immunomodulators
Humira CF Pen 40 mg/0.4 ml
2 pens
Kineret 100 mg/0.67 ml syringe
30 syringes
If you have any questions, please call Member Service at the number on the front of your ID card.
Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary, Effective January 1, 2021
Beginning January 1, 2021, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Be excluded from coverage (exceptions won’t be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
*This doesn’t include Medex 2 plans with Blue MedicareRxTM (PDP) prescription drug coverage.
Medications No Longer Covered Starting January 1, 2021
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if these medications are medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
1. These products are eligible for $0 copay with a prescription, under the Affordable Care Act.
Medications Excluded from Coverage
The following medications will be excluded from our pharmacy benefit as of January 1, 2021. You’ll be responsible for the full cost of these medications when filling a prescription at the pharmacy. This change will apply to all commercial plans, group Medex®´plans with pharmacy benefits, and Managed Blue for Seniors. Formulary exceptions won’t be accepted for these medications.
Medication Name
diclofenac 1% gel1
Niacor 500 mg2
niacin 500 mg IR2
Voltaren 1% gel1
1. This medication is available over-the-counter without a prescription.
2. Over-the-counter alternatives that don’t require a prescription are available for this medication.
Medications Switching Tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease.
Medication Class
Medication Name
2021 Tier for members with a three-tier pharmacy benefit
2021 Tier for members with a four-tier pharmacy benefit
2021 Tier for members with a five-tier pharmacy benefit
2021 Tier for members with a six-tier pharmacy benefit
Bone Marrow Stimulants
Ziextenzo
Tier 3a
Tier 4a
Tier 5a
Tier 6a
High-Cost Generic Agents
amlodipine/benazepril
Tier 2b
Tier 3b
Tier 2b
Tier 3b
carbidopa/levodopa/entacapone
Tier 2b
Tier 3b
Tier 2b
Tier 3b
diclofenac/misoprostol
Tier 2b
Tier 3b
Tier 2b
Tier 3b
dutasteride/tamsulosin
Tier 2b
Tier 3b
Tier 2b
Tier 3b
trandolapril/verapamil
Tier 2b
Tier 3b
Tier 2b
Tier 3b
High triglyceride treatments
fenofibrate 40 mg, 43 mg, 120 mg, and 130 mg
Tier 2b
Tier 3c
Tier 2b
Tier 3c
Topical Antiviral Treatments
Acyclovir cream
Tier 2b
Tier 3b
Tier 2b
Tier 3b
Acyclovir ointment
Tier 1c
Tier 1c
Tier 1c
Tier 1c
a. This medication was previously covered at Tier 2 and requires step therapy.
b. This medication was previously covered at Tier 1.
c. This medication was previously covered at Tier 2.
Medications with New Quality Care Dosing Limits
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, some of the medications listed below now require Quality Care Dosing (QCD), while the QCD limit has changed for others.
Medication Class
Medication Name
Quality Care Dosing Limit per prescription
Immunomodulators
Actemra 162 mg/0.9 ml syringe
4 syringes
Actemra Actpen 162 mg/0.9 ml
4 pens
Cimzia 200 mg vial kit
6 vials
Cimzia 2x200 mg/ml syringe kit
2 kits
Cimzia 2x200 mg/ml start kit
6 syringes
Humira CF 10 mg/0.1 ml syringe
2 syringes
Humira CF 20 mg/0.2 ml syringe
2 syringes
Humira CF 40 mg/0.4 ml syringe
2 syringes
Humira CF Pedi-Crohn’s 80-40 mg kit
2 syringes
Humira CF Pedi-Crohn’s 80 mg/0.8 ml kit
2 syringes
Humira CF Pen 40 mg/0.4 ml
2 pens
Kineret 100 mg/0.67 ml syringe
30 syringes
Olumiant 1 mg tablets
30 tablets
Orencia 50 mg/0.4 ml syringe
4 syringes
Orencia 87.5 mg/0.7 ml syringe
4 syringes
Orencia ClickJect 125 mg/ml autoinjector
4 autoinjectors
Orencia 250 mg vial
4 vials
Otezla 28-day starter pack
55 tablets (1 pack)
Rinvoq ER 15 mg tablets
30 tablets
Stelara 45mg/0.5ml vial
1 vial
Stelara 45 mg/0.5 ml syringe
1 syringe
Stelara 90 mg/ml syringe
1 syringe
Topical Antiviral Treatments
acyclovir cream
Zovirax cream
two tubes per prescription
two tubes per prescription
Effective October 1, 2020, Inflectra Is Now Preferred over Remicade for Members with Existing Prescriptions
Effective October 1, 2020, the immune-modulating medication Inflectra is now the preferred brand-name medication over Remicade. This affects members 18 years and older with existing prescriptions, and applies to prescriptions covered under the medical and pharmacy benefit.
If you’re currently taking Remicade, you should have received a letter from us with the details of this coverage change, encouraging you to talk to your doctor about switching to Inflectra before your prior authorization for Remicade expires. If your doctor determines Remicade is medically necessary, your doctor can request an exception for coverage. If the exception is approved, you'll pay the highest-tier cost when filling the medication under the pharmacy benefit. If filling the medication under the medical benefit, you'll pay your usual out-of-pocket costs.
Prior authorization is required for Inflectra and Remicade prescriptions.
Questions?
If you have any questions, call the Member Service number on the front of your ID card.
Sam’s Club Will Remain in Our Pharmacy Network
We’re pleased to announce that Sam’s Club will remain in our pharmacy network. You can continue to fill prescriptions at Sam’s Club pharmacy locations without interruption to your coverage.
If you recently filled a prescription at Sam’s Club, and received letters explaining that the pharmacy would be leaving the network, you can disregard these letters. New letters will be sent to you, confirming that the pharmacy will stay in-network.
Questions?
If you have any questions, please call Member Service at the number on your ID card.
Changes to Our Specialty Pharmacy Network for Fertility Medications
Beginning August 31, 2020, AcariaHealth™ Fertility will no longer participate in our specialty pharmacy network for fertility medications. This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the National Preferred Formulary (NPF).
Members will be able to complete their current course of treatment with AcariaHealth Fertility; however, specialty fertility medications purchased through AcariaHealth Fertility after August 31, 2020, will no longer be covered. We’ll contact members who fill their prescriptions at AcariaHealth Fertility to let them know that the pharmacy is leaving our specialty fertility network, and help them transition to another in-network specialty pharmacy for fertility medications. This change only applies to AcariaHealth Fertility and our specialty fertility network. AcariaHealth Fertility’s parent company, AcariaHealth, will remain in our specialty pharmacy network.
Specialty pharmacies provide specialty medications that are used to treat certain complex health conditions. For more information about specialty medications, use our Medication Lookup tool.
If you have any questions, please call Member Service at the number on the front of your ID card.
Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary, Effective October 1, 2020
Effective October 1, 2020, we're updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. This update includes changes that were originally scheduled to go into effect on May 1 and July 1. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Be excluded from coverage (exceptions won’t be granted)
Switch tiers
Have new quantity or dosing limits
Require step therapy
*This doesn’t include Medex 2 plans with Blue MedicareRx™ (PDP) prescription drug coverage.
Medications No Longer Covered Starting October 1, 2020
After carefully reviewing each medication's cost and their clinically appropriate covered alternatives, we've removed the medications listed below from our list of covered medications. However, a doctor may request an exception if these medications are medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class
Medication Name
Covered Alternative
Acne (topical)
Differin 0.3% gel pump
Adapalene 0.3% gel
Retin-A cream
Tretinoin cream
Acne (topical)/Psoriasis
Fabior 0.1% foam
Tazorac 0.5% and 0.1% cream
Tazorac 0.5% and 0.1% gel
1. This over-the-counter product is eligible for $0 copay with a prescription, under the Affordable Care Act.
2. This over-the-counter product is excluded from coverage. Exceptions won’t be accepted.
3. The quantity limit for this medication is 4 units per prescription, unless an exception is approved for more.
4. The quantity limit is increasing from 4 to 6 tablets per prescription on October 1, 2020.
Compounded Medications Excluded from Coverage
The following compounded medications will be excluded from our pharmacy benefit, effective October 1, 2020. If any of these medications is used as an ingredient in a compounded medication in the exact strength and form listed below, you may be responsible for the full cost of the medication. This change will apply to all medical plans, group Medex* plans with pharmacy benefits, and Managed Blue for Seniors with pharmacy benefits. Formulary exceptions won’t be accepted for these medications.
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a higher tier under certain pharmacy plans and may cost more.
Medication Class
Medication Name
2020 Tier for members with a
three-tier pharmacy benefit
2020 Tier for members with a
four-tier pharmacy benefit
2020 Tier for members with a
five-tier pharmacy benefit
2020 Tier for members with a
six-tier pharmacy benefit
Erectile Dysfunction (oral)
Tadalafil
Tier 3a
Tier 4b
Tier 3a
Tier 4b
Erectile Dysfunction (oral)
Vardenafil
Tier 3a
Tier 4b
Tier 3a
Tier 4b
a. This medication was previously covered at Tier 1.
b. This medication was previously covered at Tier 2.
Medications with New Quality Care Dosing Limits
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, some of the medications listed below now require Quality Care Dosing (QCD), while the QCD limit has changed for others.
Medication Class
Medication Name
Quality Care Dosing Limit per prescription
Antibiotics (topical)
Clindamycin Phosphate 1% foam
100 GM
Clindamycin Phosphate 1% gel
150 GM
Clindamycin Phosphate 1% lotion
120 ml
Clindamycin Phosphate 1% solution
60 ml
Clindamycin Phosphate 2% cream
80 GM
Mupirocin 2% cream
60 GM
Mupirocin 2% ointment
44 GM
Anticholinergics (inhaled)
Tudorza Pressair 400 mcg inhaler
2 inhalers
Yupelri 175 mcg/3 ml solution
30 vials
Antifungals (topical)
Econazole Nitrate 1% cream
170 GM
Ketoconazole 2% cream
120 GM
Ketoconazole 2% shampoo
240 ml
Antimuscarinics (inhaled)
Spiriva Handihaler 18 mcg inhaler
30 capsules
Beta Agonists (long-acting, inhaled)
Brovana 15 mcg/2 ml solution
120 ml
Perforomist 20 mcg/2 ml solution
60 ml
Combinations (inhaled)
Stiolto RespiMat inhaler
1 inhalation cartridge (4 GM)
Corticosteroids (inhaled)
Alvesco 80 mcg inhaler
6.1 GM (1 inhaler)
Asmanex Twisthaler 110 mcg,
220 mcg inhaler
1 inhaler
Flovent Diskus 50 mcg, 100 mcg, 250 mcg
60 blisters
Flovent HFA 44 mcg, 110 mcg,
220 mcg
1 inhaler
Pulmicort Flexhaler 90 mcg inhaler
1 inhaler
Pulmicort Flexhaler 180 mcg inhaler
2 inhalers
Pulmicort Respule 0.25 mg/2 ml, 0.5 mg/2 ml
60 ml (30 ampules)
Pulmicort Respule 1 mg/2 ml
30 ml (15 ampules)
QVAR 40 mcg inhaler
10.6 GM (1 inhaler)
SSRI (Antidepressants)
Prozac 40 mg, Fluoxetine 40 mg
Limits removed1
Zoloft 100 mg, Sertraline 100 mg
Quality Care Dosing limits were removed for these medications on July 1, 2020.
Medications That Now Require Step Therapy
Step Therapy is a key part of our Prior Authorization program. It enables us to help doctors provide members with an appropriate and affordable medication treatment. Before coverage is allowed for certain costly “second-step” medications, we require that members first try an effective, but less expensive, “first-step” medication. Some medications may have multiple steps.
The following medications now require Step Therapy. This change only applies to new prescriptions. Members with a claim for any of these medications within the previous 130 days can continue their therapy without interruption.
If you have any questions, please call Member Service at the number on the front of your ID card.
Coverage Update for Truvada
On July 1, 2020, we’ll begin covering Truvada, an HIV pre-exposure prophylaxis (PrEP) medication, at no additional cost for members who aren’t currently filling other HIV medications. Members taking other HIV medications, or are switching from an HIV medication to Truvada, will have to pay their usual out-of-pocket costs, including copays, co-insurance, and deductibles. This change applies to new prescriptions and refills, and to plans with either the Blue Cross Blue Shield of Massachusetts Formulary or National Preferred Formulary. However, the change doesn’t apply to grandfathered plans that don’t comply with the Affordable Care Act.
When the generic version of Truvada is released, we’ll start covering the generic version (instead of Truvada) at no additional cost for members who aren’t currently filling other HIV medications. At that time, members who continue to take Truvada, whether they’re taking additional HIV medications or not, will have to pay their usual out-of-pocket costs, including copays, co-insurance, and deductibles.
If you have any questions, please call Member Service at the number on the front of your ID card.
Coverage Change for Breast Cancer Risk-Reduction Medications
On October 1, 2020, we’ll begin covering the following generic oral medications in the class of aromatase inhibitors at no additional cost for members when the medications are prescribed to reduce breast cancer risk:
Anastrozole
Exemestane
Letrozole
This change applies to plans with either the Blue Cross Blue Shield of Massachusetts Formulary or the National Preferred Formulary. However, this change doesn’t apply to grandfathered plans that don’t comply with the Affordable Care Act.
If you have any questions, please call Member Service at the number on the front of your ID card.
Upcoming 4th-Quarter Changes to the Blue Cross Blue Shield of Massachusetts Formulary
In the fourth quarter of 2020, we're updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´ plans with a three-tier pharmacy benefit. This update includes changes that were originally scheduled to go into effect on May 1 and July 1. As part of these updates, certain medications may:
No longer be covered (exceptions may be granted)
Be excluded from coverage (exceptions won’t be granted)
Medications That Now Require Prior Authorization, Effective April 1, 2020
Effective April 1, 2020, until further notice, the following medications will have quantity limits for first-time prescriptions for new therapies:
Chloroquine Phosphate
Hydroxychloroquine
Plaquenil
If a medication is prescribed for more than 10 days, your doctor will be required to obtain Prior Authorization from us before additional medication can be covered and dispensed.
If you have any questions, please call Member Service at the number on the front of your ID card.
July 1st Formulary Changes Temporarily Delayed
In a recent Direct to You newsletter we notified you of upcoming formulary (list of covered medications) changes for July 1st that affected medical plans with pharmacy benefits as well as Medex® ́ plans with a three-tier pharmacy benefit. These changes have been temporarily delayed.
If you have any questions, please call Member Service at the number on the front of your ID card.
May 1st Formulary Changes Temporarily Delayed
We recently notified you of upcoming formulary (list of covered medications) changes for May 1st that affected medical plans with pharmacy benefits as well as Medex®´ plans with a three-tier pharmacy benefit. These changes have been temporarily delayed.
If you have any questions, please call Member Service at the number on the front of your ID card.
Upcoming changes to the Blue Cross Blue Shield of Massachusetts formulary, effective May 1,2020 - Delayed
Beginning May 1, 2020, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®' plans with a three-tier pharmacy benefit. As part of these updates, certain medications may:
No longer be covered (exceptions may be granted)
Medications no longer covered starting May 1, 2020
After carefully reviewing each medication’s cost and covered alternatives, we've removed the medications listed in the table below from our list of covered medications. However, your doctor may request an exception if these medications are medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
If you have any questions, please call Member Service at the number on the front of your ID card.
Changes to our speciality pharmacy network
Beginning March 31, 2020, BriovaRx®'' will no longer participate in our specialty pharmacy network. This change applies to the Blue Cross Blue Shield of Massachusetts formulary, and the National Preferred Formulary (NPF). This doesn't affect members who have Medicare Advantage with a Part D prescription drug plan; they can continue to use BriovaRx without interruption.
Unless you have Medicare Advantage with a Part D plan, you’ll no longer be covered for specialty medications purchased through BriovaRx. We’ll contact members who fill their prescriptions at BriovaRx to let them know that the pharmacy has left our network, and help them transition to an in-network specialty pharmacy.
Specialty pharmacies provide specialty medications that are used to treat certain complex health conditions. For more information about specialty medications, use the Medication Lookup tool.
If you have any questions, please call Member Service at the number on the front of your ID card.
Changes to your prescription coverage
Beginning January 1, 2020, we’re updating our list of covered medications for medical plans with pharmacy benefits, as well as Medex®' plans with a three-tier pharmacy benefit. As part of these updates, certain medications may:
No longer be covered (exceptions may be granted)
Be excluded from coverage (exceptions won’t be granted)
Switch tiers
Have new quantity or dosing limits
Medications no longer covered in 2020
After carefully reviewing each medication's cost and covered alternatives, we've removed the medications listed in the table below from our covered medications list. However, your doctor may request an exception if these medications are medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class
Medication Name
Covered Alternative
Epinephrine Injections
Adrenaclick (Authorized Generic Product)
Epinephrine Auto-Injector
EpiPen Auto-Injector
Inhaled Anticholinergic for chronic obstructive pulmonary disease
Tudorza inhaler
Spiriva RespiMat
Spiriva HandiHaler
Laxative
Lactulose 10 gm packet
Lactulose syrup
Stimulants
Strattera*
Atomoxetine
Nonsteroidal Anti-Inflammatory
Fenoprofen 200 mg and 400 mg capsules
Fenoprofen 600 mg tablets
Ophthalmic Dry eye Treatment
Restasis MultiDose
Restasis Single Use vials (requires prior authorization)
Oral Acne Treatment
Doxycycline IR-DR
Doxycycline Hyclate
Doxycycline Monohydrate
Oral Antihistamine
Carbinoxamine 6 mg tablets
Carbinoxamine 4 mg tablets
Oral Muscle Relaxants
Chlorzoxazone 250 mg, 375 mg, and 750 mg tablets
Chlorzoxazone 500 mg tablets
Topical Acne Treatment
Aktipak gel pouch
Erythromycin/Benzoyl Peroxide
Topical Vitamin D
Sorilux Foam
Calcipotriene Cream
Weight Loss
Belviq
Belviq XR
Saxenda
Contrave ER
*If you currently take Strattera, your medication will continue to be covered until the current authorization expires. However, you’ll pay the highest-tier cost.
Medications excluded from coverage
The following medications will be excluded from our pharmacy benefit as of January 1, 2020. You’ll be responsible for the full cost of these medications when filling a prescription at the pharmacy. This change will apply to all commercial plans, group Medex®'plans with pharmacy benefits, and Managed Blue for Seniors. Formulary exceptions won’t be accepted for these medications
Medication or Supply Name
Bensal HP1
Epiduo1
Pliaglis2
Prilocaine 7%/Tetracaine 7%2
Sil-k 2” X 5” Pad3
Over-the-counter alternatives that don’t require a prescription are available for this medication.
This medication isn’t available over-the-counter and is only available for medical professional use.
Coverage for bandages isn’t included under our pharmacy benefit.
This medication is available over-the-counter without a prescription.
Medications switching tiers
When the cost of a medication changes, we may move it to a different tier. The medications listed below are moving to a higher tier under certain pharmacy plans and may cost more.
Medication Class
Medication Name
2020 Tier for members with a
three-tier pharmacy benefit
2020 Tier for members with a
four-tier pharmacy benefit
2020 Tier for members with a
five-tier pharmacy benefit
2020 Tier for members with a
six-tier pharmacy benefit
Topical Antiviral
Acyclovir Ointment
Tier 2a
Tier 3b
Tier 2a
Tier 3b
Granulocyte Stimulating Factor
Nivestym
Tier 3b
Tier 4c
Tier 5d
Tier 6e
This medication was previously covered at Tier 1.
This medication was previously covered at Tier 2.
This medication was previously covered at Tier 3.
This medication was previously covered at Tier 4.
This medication was previously covered at Tier 5.
Medications with new quality care dosing limits
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, we’re reducing Quality Care Dosing Limits for the following medications:
Expanded access to certain cholesterol medications
In 2020, you’ll be able to fill prescriptions for Praluent and Repatha at any retail pharmacy that has access to these medications in the Express Scripts®' network.* Previously, these medications, which are known as PCSK9 agents and are typically used to lower cholesterol levels, were only available through in-network specialty pharmacies.
*Please note that these medications may not be available at all pharmacies.
Coverage of Opioid Alternatives, and Change in Massachusetts’ "Partial Fill" Law
For members who prefer not to use opioids, a class of medication that includes OxyContin and Vicodin and is sometimes prescribed by doctors to treat pain, our standard plans cover a wide range of alternative treatment options, including more than 500 non-opiate medications (nonsteroidal anti-inflammatory drugs, and topical analgesics).*
We also cover several specialty services, combining therapies to offer individualized treatment for pain management, including:
physical and occupational therapy (PT/OT)
chiropractic treatment
pain medicine specialists
transcutaneous electrical nerve stimulation (TENS) units
acupuncture (beginning January 1, 2020 for new or renewed plans)
We’ll be adding an Alternatives to Opioids section to the Medication Lookup tool by the end of December. That’s where you’ll find an Alternatives to Opioids fact sheet and medication list.
Also, due to a recent change in Massachusetts’ “partial fill” law, there’s no extra charge if you choose to partially fill your narcotic or opioid prescription. You won’t be charged an additional copay if you fill the remainder of your prescription at the same pharmacy within 30 days.
*For more information about coverage for non-opiate medications, members should check their pharmacy benefit materials. For covered pain management services, they should check their medical benefit materials.
National Prescription Drug Take Back Day is October 26, 2019
Medications don’t last forever. Over time, their chemical properties change, making them less potent—and even dangerous. Take the time to go through your medicine cabinets and check for any expired or unwanted medications—this includes everything from aspirin to prescription medications.
The U.S. Drug Enforcement Administration’s next National Prescription Drug Take Back Day is Saturday, October 26, 2019, from 10:00 a.m. to 2:00 p.m. Anyone can take part by bringing expired or unused medications to a local disposal location.
Changes to our speciality pharmacy network and medication list
Beginning July 1, 2019, we’ll make the following changes to our retail specialty pharmacy network and to the medications these pharmacies can fill.
AllianceRx Walgreens Prime will leave our retail specialty pharmacy fertility network
AllianceRx Walgreens Prime will no longer be in our retail specialty pharmacy fertility network. If you’re receiving specialty fertility medications through AllianceRx Walgreens Prime, you can complete the medications for your current cycle, but we won’t cover prescriptions filled at AllianceRx Walgreens Prime on or after July 1, 2019. If this change impacts you, we’ll reach out to you directly.
BriovaRx® will leave our fertility network, but remain in our specialty network
BriovaRx will no longer be in our fertility network, but will continue to fill other prescriptions in our Specialty Network. If you’re receiving fertility medications through BriovaRx, you can complete the medications for your current cycle, but we won’t cover fertility prescriptions filled at BriovaRx on or after July 1, 2019. If this change impacts you, we’ll reach out to you directly.
Updates to our specialty pharmacy medication list
Beginning July 1, 2019, we’ll cover additional medications and new-to-market medications in our specialty pharmacy network.
Medications now available through our specialty pharmacy network:
Cinryze
Haegarda
Berinert
Kalbitor
Ruconest
New-to-market medications:
Abiraterone
Alyq
Carmustine
Daurismo
Inbrija
Ledipasvir/Sofosbuvir
Lorbrena
Lumoxiti
Oxervate
Panzyga
Sofosbuvir/Velpatasvir
Talzenna
Tegsedi
Udenyca
Vitrakvi
Vizimpro
Questions?
If you have any questions, please call Member Service at the number on the front of your ID card.
Introducing our new Medication Lookup Tool
With our new and improved Medication Lookup tool, you can easily determine which medications are covered by your plan. You’ll also find covered alternatives to non-covered medications, as well as which medications have additional requirements before being prescribed. You can use the tool to:
Search for any medication
View medications by strength
See medications by how they’re dispensed, such as pills, liquids, and injections
Learn which medications have additional requirements, such as Prior Authorization, Step Therapy, and Quality Care Dosing
See covered alternatives for non-covered medications
If you have any questions, please call Member Service at the number on the front of your ID card.
*A medication’s tier is based on your plan design. Knowing how many tiers your plan has can help you understand your out-of-pocket costs. Instructions to find which plan you have are included within the tool.
Coming in July 2019: upcoming changes to our pharmacy program
Beginning July 1, 2019, we’re making changes to our list of covered medications for medical plans with pharmacy benefits, as well as Medex® plans with a three-tier pharmacy benefit. We’ll notify impacted members by June 1, 2019. As part of these updates, certain medications may:
No longer be covered
Switch cost tiers
Be excluded from pharmacy benefit coverage due to over-the-counter availability
Require prior authorization
Certain medication will become non-covered
After a careful review of its cost and covered alternatives, we’ve decided to remove the medication in the table below from our list of covered medications, effective July 1, 2019. Your doctor or prescriber may request a coverage exception if the medication is medically necessary. If the request is approved, you’ll pay the highest-tier cost for the medication.
Medication Class
Medication Name
Covered Alternative
Erythropoietins
Procrit*
Retacrit
*If you’re currently prescribed to Procrit, you may continue to fill your prescription under your existing prior authorization. However, you’ll pay more as the medication will move to the highest tier.
Medications that are switching tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a higher tier, which means they may cost you more.
Medication Class
Medication Name
2019 Tier
For members with a three-tier pharmacy benefit
2019 Tier
For members with a four-tier pharmacy benefit
2019 Tier
For members with a five-tier pharmacy benefit
2019 Tier
For members with a six-tier pharmacy benefit
Topical Testosterone
Tier 3a
Tier 4b
Tier 3a
Tier 4b
Granulocyte Stimulant Factor
Tier 3a
Tier 4b
Tier 5c
Tier 6d
a This medication was previously covered at Tier 2. b This medication was previously covered at Tier 3. c This medication was previously covered at Tier 4. d This medication was previously covered at Tier 5.
Medications excluded from pharmacy benefit coverage
The following medications will be excluded from our pharmacy benefit due to over-the-counter availability. This change will apply to all commercial plans, group Medex® plans with pharmacy benefits, and Managed Blue for Seniors. Formulary exceptions won’t be accepted for these medications.
Medication Name
Differin 0.1% (All topical forms)
Adapalene 0.1% (All topical forms)
Proton pump inhibitors when included as part of a compounded medication*
*Members under the age of 18 will still be covered for these medications. However, prior authorization will be required for new prescriptions.
Medications requiring prior authorization
For certain medications, your doctor must first obtain approval before we cover it. The following medications will require prior authorization:
Axiron*
AndroGel*
Berinert
Firazyr
Gilotrif*
Haegarda
Iressa*
Kalbitor
Neulasta
Neupogen
Ruconest
Tarceva*
Tagrisso*
*If you’re currently prescribed to this medication, you may continue to fill your prescription and won’t require prior authorization.
Updates to our prior authorization requirements
Beginning July 1, 2019, our prior authorization requirements for the medications listed below are changing for members with our HMO, Access Blue, and Blue Choice® plans.
Medication Name
AdministrationBerinert
Berinert
Cinqair
Fasenra
Firazyr
Haegarda
Kalbitor
Neulasta
Neupogen
Nucala Ruconest
Prior authorization is required for these medications when administered:
In a clinician’s or physician’s office
By a home health care provider
By a home infusion therapy provider In an outpatient hospital and dialysis setting
This change doesn’t affect these medications when administered in inpatient care, surgical day care, urgent care centers, and emergency room settings.
Beginning January 1, 2019, we're making changes to our list of covered medications for medical plans with pharmacy benefits, as well as Medex® plans with a three-tier pharmacy benefit. As part of these updates, certain medications may:
No longer be covered
Switch tiers
Have a new dosing limit
Require prior authorization
Change cost
Proton pump inhibitors no longer a covered benefit in 2019
Effective January 1, 2019, proton pump inhibitors (medications commonly used to reduce stomach acid) will be excluded from your pharmacy benefit, except for members under the age of 18.
This benefit exclusion will apply to members 18 years of age and older who currently have pharmacy benefits.
This benefit exclusion will not apply to members under the age of 18.
This benefit exclusion will not apply to members being treated with combination prescription medications to treat Helicobacter pylori (H. pylori).
Exceptions will no longer be available for this class of medications, even if the member has a prescription or if we've covered it in the past.
Members should talk to their doctors about over-the-counter medication options that are available without a prescription.
This affects the following medications:
Aciphex
First-Lansoprazole
Omeprazole sodium bicarbonate
Rabeprazole
Aciphex Sprinkle
First-Omeprazole
Pantoprazole
Zegerid
Dexilant
Lansoprazole
Prevacid
Esomeprazole magnesium
Nexium
Prilosec
Esomeprazole strontium
Omeprazole
Protonix
Medications no longer covered in 2019
After carefully reviewing each medication's cost and covered alternatives, we've removed the medications listed in the table below from our covered medications list. However, a doctor may request an exception if these medications are medically necessary. If the exception is approved, the member will pay the highest-tier cost.
Medication Class
Non-Covered Medication or Supply
Covered Alternative
Anticoagulants
(medications to treat and prevent blood clots)
Pradaxa*
Eliquis, Xarelto, warfarin
Colchicine Products
(medications to treat gout)
Single-source colchicine products (colchicine products that resemble generic versions in name only)
Colcrys, Mitigare
Dopamine Agonists
(treatment for Parkinson's disease)
Mirapex
ropinirole, pramipexole
Glucagon-Like Peptide 1
Agonists (injectable medications to treat diabetes)
Victoza
Byetta, Bydureon, Trulicity
Granulocyte Stimulants
(white blood cell replacement agents used during chemotherapy)
Neupogen**††
Zarxio††, Granix††
Ophthalmic Anti-Inflammatory
(short-term medications to treat inflammation in the eye)
FML S.O.P., FML Liquifilm, Pred Mild, Maxidex, Flarex
Lotemax, generic ophthalmic steroid medications
*Members currently using Pradaxa will be given an exception to continue their coverage until December 31, 2019, but they'll pay the highest-tier cost since the medication will no longer be covered.
**Members currently using Neupogen will be given an exception to continue their coverage until May 31, 2019, but they'll pay the highest-tier cost since the medication will no longer be covered. ††This medication must be filled at an in-network retail specialty pharmacy.
Medications that are switching tiers
When the cost of a medication changes, we may move the medication to a different tier. Depending on the tier change, your payment for the following medications may increase or decrease:
These medications are moving to a higher tier, which means they may cost you more.
Medication Class
Medication Name
2019 Tier
(for members with a three-tier pharmacy benefit)
2019 Tier
(for members with a four-tier pharmacy benefit)
2019 Tier
(for members with a five-tier pharmacy benefit)
2019 Tier
(for members with a six-tier pharmacy benefit)
These medications are moving to a lower tier, which means they may cost you less.
Medication Class
Medication Name
2019 Tier
(for members with a three-tier pharmacy benefit)
2019 Tier
(for members with a four-tier pharmacy benefit)
2019 Tier
(for members with a five-tier pharmacy benefit)
2019 Tier
(for members with a six-tier pharmacy benefit)
DPP4/SGLT2 Inhibitor Combinations
(oral medications to treat diabetes)
Glyxambi
Tier 2e
Tier 3e
Tier 2e
Tier 3e
Insulins - Basal
Basaglar
Tier 2e
Tier 3e
Tier 2e
Tier 3e
Multiple Sclerosis: Beta-Interferons
Plegridy††
Tier 2e
Tier 3e
Tier 4e
Tier 5e
Novel Psychotropics: Long Acting
(medications to treat psychological disorders)
Abilify- Maintena
Tier 2e
Tier 3e
Tier 2e
Tier 3
a This medication was previously covered at Tier 2. b This medication was previously covered at Tier 3. c This medication was previously covered at Tier 4. d This medication was previously covered at Tier 5. e This medication wasn't previously covered. ††This medication must be filled at an in-network retail specialty pharmacy.
Medications with new Quality Care Dosing Limit
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, we're reducing Quality Care Dosing Limits for the following medications:
Medication Name
Quality Care Dosing Limit
Morphabond ER 60mg
60 per prescription
Morphabond ER 100mg
30 per prescription
Medications requiring prior authorization (for new prescriptions only)
Your doctor is required to obtain prior authorization before we'll cover certain medications. The following medications will require prior authorization for new prescriptions in 2019. Members currently taking the medications will be given an exception and won't need prior authorization:
Breo Ellipt
Higher costs for medications with supplies longer than 30 days
The cost for the medications listed below is increasing. These medications are usually dispensed in a supply longer than 30 days. We've typically only charged members a 30-day copayment for these medications. Beginning January 1, 2019, members will have to pay an adjusted copayment based on the supply length.†
For example: if your copayment is $25 for a 30-day supply, you'll pay $75 for a 90-day supply.
fluphenazine decanoate
Lupron Depot Pediatric††
Eligard††
Zoladex††
leuprolide acetate††
haldol decanoate
Lupron Depot††
haloperidol decanoate
† This change only applies to members with a prescription plan that uses a copayment.
You may be able to save money for long-term medications, also known as maintenance medications, when you order prescriptions through our mail order pharmacy. Learn more at MyBlue, or get started online by visiting Express Scripts®, an independent company that manages your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts. You can also call them directly at 1-800-892-5119.
Questions about your treatment options
If these changes affect you and you have questions about your treatment options, such as whether a less expensive medication is available, please talk to your doctor.
New changes to our speciality pharmacy network
Effective September 1, 2018, we'll be making the following changes to our specialty pharmacy network:
BriovaRx®will join.
AllianceRx Walgreens Prime will leave, but will remain within our fertility network.
AllCare Plus Pharmacy and On co360 will also leave.
If you fill your prescription at one of the pharmacies that will be leaving our network, you'll receive a letter from us by August 1 to help you transition to an in-network pharmacy.
Specialty pharmacies provide medications that are used to treat certain complex health conditions.
Questions?
If you have any questions or need help transitioning to an in-network pharmacy, please call Member Service at the number on the front of your ID card.
Upcoming changes to our specialty pharmacy network
Beginning September 1, 2018, we’re making changes to our specialty pharmacy network. As part of these changes AllCare Plus Specialty Pharmacy and On co360 will be leaving the network. Prescriptions for specialty medications from AllCare Plus and On co360 will no longer be covered. If you fill your prescription at either of these pharmacies, we’ll contact you by August 1, 2018 to help you transition to an in-network specialty pharmacy. Specialty pharmacies provide medications that are used to treat certain complex health conditions. You can view our Specialty Medications list.
Introducing Diabetes Care Value, a new way to engage and support members with diabetes
We're excited to introduce Diabetes Care Value, our newest program to support members with diabetes who are over 18. This program helps members regularly monitor blood glucose levels and manage diabetes medications, and offers incentives for making healthy choices. Beginning July 1, 2018, eligible members will receive communications in the mail from our partners, Express Scripts® and Mango Health*, with instructions on how to enroll.
The Diabetes Care Value program features:
Tracking and monitoring of blood glucose readings with a OneTouch Verio Flex® meter, available at no additional cost. This meter pairs with the OneTouch Reveal® mobile app to track blood glucose readings.
Access to specially trained pharmacists who monitor glucose readings through the OneTouch Reveal app and provide tailored coaching when issues are identified over time.
Rewards and incentives for staying on track with diabetes medications and making healthy choices through Mango Health, a medication management app. Available at no additional cost, Mango Health is IOS and Android compatible.
Questions? Contact Express Scripts at 855-723-6099 and ask to speak to a pharmacist specializing in diabetes.
*Express Scripts and Mango Health are independent companies, working on behalf of Blue Cross Blue Shield of Massachusetts.
Update regarding changes to continuous glucose monitor sensor coverage
In March, we featured an article in our Direct to You newsletter and online on our MyBlue® Pharmacy Updates page stating that beginning July 1, 2018, we would provide coverage for continuous glucose monitor (CGM) sensors under the Durable Medical Equipment (DME) benefit.
We have decided that coverage for CGM sensors will remain unchanged. As a result, CGM sensors will continue to be covered by your medical plan's pharmacy benefit.
If you have any questions, call the Member Service number on the front of your ID card.
You can refer to the original change announcement below.
Changes to continuous glucose monitor sensor coverage
Beginning July 1, 2018, we'll provide coverage for continuous glucose monitors (CGMs) sensors under the Durable Medical Equipment (DME) benefit. Previously, CGM sensors were covered under the pharmacy benefit.
The move to DME was made, in part, to ease confusion regarding coverage requirements for the CGM sensors. If you don't have pharmacy coverage but already have coverage for the CGM sensors under DME benefits, there's no change to your plan.
We will notify impacted members of this change by letter prior to June 1, 2018.
If you have any questions, call the Member Service number on the front of your ID card.
New prior authorization requirements for HMO, Access Blue, and Blue Choice®plans
Beginning July 1, 2018, prior authorization is required for the medications listed below when administered:
In a doctor's office
By home health care providers
By home infusion therapy providers
In outpatient hospital and dialysis settings
This change doesn't affect these medications when used in inpatient, surgical day care, urgent care centers, and ER settings. We encourage you to discuss this change with your health care provider.
Medications that require prior authorization:
Cosentyx
Hemlibra
Inflectra
Kevzara
Rebinyn
Renflexis
Siliq
Taltz
Tremfya
Tretten
Coming in July 2018: changes to our pharmacy program
Beginning July 1, 2018, we're making changes to our covered medications list for medical plans with pharmacy benefits, and Medex®plans with the three-tier pharmacy benefit. As part of these updates, certain medications will do one of the following:
Switch tiers
No longer be covered
Have a new dosing limit
Medications that are switching tiers
When the cost of a medication changes, we move the medication to a different tier. Depending on the tier change, your payment for the following medications may increase or decrease:
Medication Class
Medication Name
New Tier as of July 1, 2018 (applies to members with a 3-tier or 5-tier pharmacy benefit)
New Tier as of July 1, 2018 (applies to members with a 4-tier or 6-tier pharmacy benefit)
Dermatological
Doxepin cream
Tier 21
Tier 32
Inhaled combination for chronic obstructive pulmonary disease
Tier Anoro Ellipta
Tier 21
Tier 32
1 This medication was previously covered at Tier 1. 2 This medication was previously covered at Tier 2.
Medications no longer covered
After carefully reviewing each medication's cost and covered alternatives, we've removed the medications listed in the chart below from our covered medications list. However, when these medications are medically necessary, your prescribing doctor may request a coverage exception.
Medication Class
Non-Covered Medication or Supply
Covered Alternative
Multi-Source Brands
Provigil Lidoderm Patch
Modafinil Lidocaine Patch
Medications with a new Quality Care Dosing Limit
To make sure that the quantity and dose of a medication meets the Federal Drug Administration, manufacturer, and clinical recommendations, we’re adding a Quality Care Dosing Limit to the following medications:
For This Medication
The Quality Care Dosing Limit for Each Prescription
Additional Information
Naloxone Carpuject (vial and syringes)
Two per 30 days
This medication will also be available at no cost for eligible members. If you have a Saver plan, the deductible will apply first. Please call Member Service at the number on your ID card, or check your benefit materials to see if you're eligible.
Narcan nasal spray
Two per 30 day
Evzio
Two per 30 day
N/A
Proton pump inhibitors to be excluded from pharmacy coverage in 2019
Beginning January 1, 2019, all proton pump inhibitors will be excluded from our pharmacy benefit coverage, except for members under the age of 18 and those taking combination medications to treat H. Pylori. Formulary exceptions, including those previously approved, will no longer be available for this class of medication, except for members under the age of 18 and those taking combination medications to treat H. Pylori.
This change applies to the following plans with pharmacy benefits:
Individual plans
Massachusetts Health Connector plans
Medex plans with 3-tier pharmacy benefits
Walgreens Specialty Pharmacy Is Now AllianceRx Walgreens Prime
One of the specialty pharmacies in our retail network, Walgreens Specialty Pharmacy, has changed its name to AllianceRx Walgreens Prime. AllianceRx Walgreens Prime delivers specialty pharmacy services to individuals with complex medical conditions.
If you're already using this specialty pharmacy for any medication, no action on your part is required. AllianceRx Walgreens Prime will continue to fill prescriptions—just under its new name. Phone and fax numbers remain the same for now, but the website has been updated to reflect the name change.
$0 Copay for some statin medications starting December 1, 2017
Pharmacy benefit update for statins, effective December 1, 2017
To comply with the Affordable Care Act, starting December 1, 2017, the following statin medications will be covered at no cost* for members that meet the conditions listed below.
Atorvastatin 10-20 mg
Fluvastatin IR and XL 20-80 mg
Lovastatin 10-40 mg
Pravastatin 10-80 mg
Rosuvastatin 5-10 mg
Simvastatin 5-40 mg
Members must meet the following criteria:
No history of cardiovascular disease (CVD) (i.e., symptomatic coronary artery disease or ischemic stroke)
Meet the age requirement (40 to 75)
Have one or more CVD risk factors (dyslipidemia, diabetes, hypertension, or smoking)
Have a calculated 10-year risk of a cardiovascular event of 10% or greater
Questions?
If you have any questions, please call Member Service at the number on the front of your Blue Cross ID card. For more information about your prescription coverage, visit bluecrossma.com/pharmacy. *For qualified members.
Pharmacy program changes coming in 2018
Beginning January 1, 2018, we're making changes to our covered medications list for medical plans with pharmacy benefits, and Medex® plans with the three-tier pharmacy benefit.
These changes affect:
Medication coverage
Medication dosing limits
Medications no longer covered as of 2018
After reviewing each medication's cost and covered alternatives, we've removed the medications listed in the chart below from our covered medications. However, when these medications are medically necessary, a member's doctor or prescriber may request a coverage exception; if approved, the medication will process at the highest tier
Medication Class
Non-Covered Medication or Supply
Covered Alternative
Biguanides for Diabetes
Generic Metformin Film Coated ER version of Fortamet
Metformin 500mg, 850mg, 1000mg(Generic version of Glucophage)
Metformin ER 500mg, 750mg (Generic version of Glucophage XR)
*Existing users may continue to fill this medication but will experience a tier change.
Medication with new Quality Care Dosing Limit
To make sure that the quantity and dose of a medication meets the Federal Drug Administration, manufacturer, and clinical recommendations, we are adding a Quality Care Dosing Limit to the following medications:
Medication Name
Quality Care Dosing Limit
Humira Pediatric Crohn's Starter Pack
1 Pack (2 Syringes)
*This impacts new starts only. There will be no impacted member communications
Proton pump inhibitors will be excluded from pharmacy coverage
Beginning January 1, 2019, all proton pump inhibitors will be excluded from our pharmacy benefit coverage, except for members under the age of 18 and those taking combination medications to treat H. Pylori. Formulary exceptions, including those previously approved, will no longer be available for this class of medication, except for members under the age of 18 and those taking combination medications to treat H. pylori.
This change applies to all commercial plans, group Medex plans with three-tier pharmacy benefits, and Managed Blue for Seniors plans. We will notify impacted members beginning in November 2018 prior to the change.
AllCare Plus Specialty Pharmacy is joining our network
This summer you'll have another retail specialty pharmacy option where you can fill prescriptions for specialty medications. Starting July 1, 2017, AllCare Plus Pharmacy is joining our retail specialty pharmacy network. Specialty pharmacies provide medications that are used to treat certain health conditions. These medications must be filled at a retail specialty pharmacy in our network. You can view our Specialty Medications List here. We're updating this list on July 1 to include the medications AllCare Plus fills. You can reach AllCare Plus at 1-855-880-1091 or allcarepluspharmacy.com.
Proton pump inhibitors will be excluded from pharmacy coverage
Beginning January 1, 2019, all proton pump inhibitors will be excluded from our pharmacy benefit coverage, except for members under the age of 18 and those taking combination medications to treat H. Pylori. Formulary exceptions, including those previously approved, will no longer be available for this class of medication, except for members under the age of 18 and those taking combination medications to treat H. pylori. This change applies to all commercial plans, group Medex plans with three-tier pharmacy benefits, and Managed Blue for Seniors plans. We're making this change because several products in this class are available over the counter.
New prior authorization requirements for HMO, Access Blue, and Blue Choice plans
Beginning September 1, 2017, prior authorization is required for the medications listed below when administered:
In doctor offices
By home health care providers
By home infusion therapy providers
In outpatient hospital and dialysis settings
This change doesn't affect these medications when used in inpatient, surgical day care, urgent care centers, and ER settings. We encourage you to discuss this change with your health care provider.
Medications that require prior authorization:
Egrifta
Exondys-51
Gel-Syn
Ixinity
Kanuma
Kovaltry
Lemtrada
NovoEight
Obizur
Spinraza
Zomacton
Changes to our pharmacy program
Beginning September 1, 2017, we're making changes to our covered medications list that will affect:
Medications switching tiers
Medications that are no longer covered
One medication moving to benefit exclusion (also impacts Managed Blue for Seniors)
Plans affected by the changes:
Commercial medical plans with pharmacy benefits
Medex® plans with the three-tier pharmacy benefit
Medications changing tier status
When the cost of a medication changes, we move the medication to a different tier. Depending on the tier change, you may be required to pay more or less for the following medications: Note:
Medication Class
Medication Name
Covered Tier Level as of September 1, 2017 under a 3 Tier Formulary
Covered Tier Level as of September 1, 2017 under a 4 Tier Formulary
Proton Pump Inhibitors (PPI)
Esomeprazole
Lansoprazole
Omeprazole Omeprazole/BiCarb
Pantoprazole
Rabeprazole
Prevacid SoluTab
Tier 3
Tier 4
Syringes
Terumo
Thinpro
Ulticare
Tier 2
Tier 3
If you're using combination prescription medications to treat H. pylori, you'll continue to pay your current cost.
Medications no longer covered
After carefully reviewing each medication's cost and covered alternatives, we've removed the medications listed in the chart below from our covered medications list for the plans referenced above. However, when these medications are medically necessary, your doctor or prescriber may request a coverage exception.
Medication Class
Non-Covered Medication or Supply
Angiotensin II Receptor Blockers (for high blood pressure)
Azor, Benicar, Benicar HCT, and Tribenzor
Antipsychotic Medications
Seroquel XR
Asthma/Allergy Treatment
Singulair
Cholesterol-Lowering Medications
Zetia
Colonoscopy Preparation/ Laxatives
Osmoprep*
Dermatological Treatments
Alcortin-A, Anusol HC Suppository, Lidocaine-HC 2%-2.5% Kit, Relador Pak, Relador Pak Plus, Salicylic Acid 6% Lotion Kit
*Since Osmoprep is a one-time use medication, we will not issue member letters.
Medication excluded from pharmacy coverage
The following medication will be excluded from our pharmacy coverage because it's cosmetic. This change will apply to all commercial plans, group Medex® plans with pharmacy benefits, and Managed Blue for Seniors. Formulary exception will not be accepted for this medication
UPDATE - Effective July 1, 2025, changes to the Standard Control with Advanced Control Specialty Formulary
Effective July 1, 2025, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
PAY SET OUT-OF-POCKET COSTS FOR SELECT MEDICATIONS
Effective on your plan renewal beginning July 1, 2025, members on select plans will pay specific out-of-pocket costs set by the Commonwealth of Massachusetts for select medications that treat the following conditions:
asthma
diabetes (select insulins)
select heart conditions, including congestive heart failure and coronary artery disease
This change is required by a new Massachusetts law and applies to select plans with the Blue Cross Blue Shield of Massachusetts formulary, and the Standard Control with Advanced Control Specialty Formulary.
To find out the cost of your medication, sign in to MyBlue and select Price a Medication under My Medications.
Effective July 1, 2025, changes to the Standard Control with Advanced Control Specialty Formulary
Effective July 1, 2025, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
Complete details about these changes will be available by May 27, 2025. Check back at that time.
UPDATE - Effective April 1, 2025, changes to the Standard Control with Advanced Control Specialty Formulary
Effective April 1, 2025, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective April 1, 2025, changes to the Standard Control with Advanced Control Specialty Formulary
Effective April 1, 2025, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
Complete details about these changes will be available by February 28, 2025. Check back at that time.
UPDATE - Effective January 1, 2025, changes to the Standard Control with Advanced Control Specialty Formulary
Effective January 1, 2025, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective January 1, 2025, Changes to the Standard Control with Advanced Control Specialty Formulary
Effective January 1, 2025, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
Complete details about these changes will be available by October 31, 2024. Check back at that time.
Changes to Our Specialty Pharmacy Network for Fertility Medications
On December 1, 2024, Encompass Fertility®´, a subsidiary of CVS Pharmacy that administers specialty fertility medications, will be leaving our specialty pharmacy network. At this time, CVS SpecialtyTM will be joining our specialty pharmacy network to administer specialty fertility medications for our members.
If you currently fill your medication through Encompass Fertility, CVS Specialty will contact you by December 1, 2024 to help you transition to CVS Specialty.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the Standard Control with Advanced Control Specialty Formulary. For more information, visit our specialty medications resource page.
Questions?
If you have any questions, call Team Blue Member Service at the number on your ID card.
UPDATE - Effective January 1, 2025, changes to the Standard Control with Advanced Control Specialty Formulary
Effective January 1, 2025, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective January 1, 2025, Changes to the Standard Control with Advanced Control Specialty Formulary
Effective January 1, 2025, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
Complete details about these changes will be available by October 31, 2024. Check back at that time.
UPDATE - Effective October 1, 2024, Changes to the Standard Control with Advanced Control Specialty Formulary
Effective October 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective October 1, 2024, Changes to the Standard Control with Advanced Control Specialty Formulary
Effective October 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
Complete details about these changes will be available by August 28, 2024. Check back at that time.
Effective May 15, 2024, Select Diabetes and Weight-Loss Medications No Longer Available Through the Mail Service Pharmacy
Effective May 15, 2024, due to a medication shortage, you won’t be able to fill the following diabetes and weight-loss medications in 90-day supplies through the mail service pharmacy:
Diabetes Medications
Weight-Loss Medications
• Mounjaro
• Trulicity
• Wegovy
• Saxenda
These medications will continue to be available in 30-day supplies through in-network retail pharmacies. If you fill these medications through the mail service pharmacy, you should have received a letter from CVS Customer Care with more information about the change.
If you want to find an in-network pharmacy that’s convenient to you, sign in to MyBlue, then select Find a Pharmacy under My Medications. You can also call Team Blue Member Service at the number on your ID card.
Questions?
If you have any questions, call CVS Customer Care at 1-877-817-0477 (TTY: 711).
On August 1, 2024, AllianceRx Walgreens Specialty Pharmacy will become Walgreens Specialty Pharmacy
AllianceRx Walgreens Specialty Pharmacy delivers specialty pharmacy services to individuals with complex medical conditions. On August 1, 2024, they’re changing their name to Walgreens Specialty Pharmacy. You don’t need to take any action if you’re currently using this pharmacy. They’ll continue to fill your covered prescriptions — just under a new name.
To reach Walgreens Specialty Pharmacy:
Phone: 1-888-347-3416
Fax: 1-877-231-8302
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
Acaria Health Is Leaving Our Specialty Pharmacy Network
On July 1, 2024, Acaria Health will be leaving our specialty pharmacy network.
If you fill your prescriptions through Acaria Health, you can complete your current course of treatment with Acaria Health, but treatments starting on or after July 1, 2024 will need to be filled through through Accredo, AllianceRx Walgreens Pharmacy, or CVS Specialty in order to be covered. If you’re currently using Acaria Health, you should have received a letter from us about next steps.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the Standard Control with Advanced Control Specialty Formulary. For more information about specialty medications, use our Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
UPDATE - Effective July 1, 2024, Changes to the Standard Control with Advanced Control Specialty Formulary
Effective July 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective July 1, 2024, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective July 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
Complete details about these changes will be available by May 31, 2024. Check back at that time.
UPDATE - Effective April 1, 2024, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective April 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective April 1, 2024, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective April 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
Complete details about these changes will be available by February 28, 2024. Check back at that time.
AllianceRx Walgreens Pharmacy Will Join Our Specialty Pharmacy Network
On January 1, 2024, AllianceRx Walgreens Pharmacy will join our specialty pharmacy network. Specialty pharmacies provide medications that are used to treat certain complex health conditions. For more information about specialty medications, use our Medication Lookup tool.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts Formulary, and the Standard Control with Advanced Control Specialty Formulary.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
UPDATE - Effective January 1, 2024, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective January 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective January 1, 2024, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective January 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
Complete details about these changes will be available by October 31, 2023. Check back at that time.
UPDATE - Effective January 1, 2024, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective January 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective January 1, 2024, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective January 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
Complete details about these changes will be available by October 31, 2023. Check back at that time.
UPDATE - Effective October 1, 2023, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective October 1, 2023, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective October 1, 2023, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective October 1, 2023, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
Complete details about these changes will be available by August 31, 2023. Check back at that time.
UPDATE - Effective July 1, 2023, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective July 1, 2023, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective July 1, 2023, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective July 1, 2023, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
Complete details about these changes will be available by May 31, 2023. Check back at that time.
UPDATE - Effective April 1, 2023, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective April 1, 2023, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective April 1, 2023, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective April 1, 2023, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
No longer be covered (exceptions may be granted)
Switch tiers
Have new quantity or dosing limits
Require prior authorization and/or step therapy
Be added to the list of covered medications
Be designated as preferred
Complete details about these changes will be available by February 28, 2023. Check back at that time.
Effective January 1, 2023, Medications Covered by the Standard Control with Advanced Control Specialty Formulary
The following medication lists include medications that are covered and non-covered by the Standard Control with Advanced Control Specialty Formulary (SC-ACSF), effective January 1, 2023. The SC-ACSF will be administered by CVS Caremark®´, an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts.
CaremarkPCS Health, LLC (“CVS Caremark”) is an independent company that has been contracted to administer pharmacy benefits and provide certain pharmacy services for Blue Cross Blue Shield of Massachusetts. CVS Caremark is part of the CVS Health family of companies. Blue Cross Blue Shield of Massachusetts is an Independent Licensee of the Blue Cross and Blue Shield Association.
Encompass Fertility™ Has Joined Our Specialty Pharmacy Network for Fertility Medications
Effective July 19, 2022, Encompass Fertility has joined our specialty pharmacy network for fertility medications. They have access to all our covered fertility medications, and they can fill and ship medications in all 50 states.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the National Preferred Formulary (NPF). For more information about specialty fertility medications, use our Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Metro Drugs Is Leaving Our Specialty Pharmacy Network for Fertility Medications
Effective May 1, 2022, Metro Drugs, a fertility medication pharmacy, will be leaving our specialty pharmacy network. If you’re taking fertility medications and fill your prescriptions through Metro Drugs, you’ll be able to complete your current course of treatment with Metro Drugs, but treatments starting after May 1, 2022 will need to be filled through Freedom Fertility Pharmacy, or Village Fertility Pharmacy in order to be covered. If you’re currently using Metro Drugs, you’ll receive a letter from us about next steps.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the National Preferred Formulary (NPF). For more information about specialty fertility medications, use our Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Effective July 1, 2022, Medications No Longer Covered Under the National Preferred Formulary
Effective July 1, 2022, Express Scripts, Inc.®´, an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the National Preferred Formulary (NPF). Included in this update are medications that will no longer be covered under the NPF.
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, Express Scripts is removing medications from their formulary. However, a doctor may request an exception if these medications are medically necessary. If the exception is approved by Blue Cross, you’ll pay the highest-tier cost.
Effective January 1, 2022, Medications No Longer Covered Under the National Preferred Formulary
Beginning January 1, 2022, Express Scripts, Inc.®´, an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the National Preferred Formulary (NPF). Included in this update are medications that will no longer be covered under the NPF.
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, Express Scripts has removed medications from their formulary. However, a doctor may request an exception if these medications are medically necessary. If the exception is approved by Blue Cross, you’ll pay the highest-tier cost.
Effective July 1, 2021, Medications No Longer Covered Under the National Preferred Formulary
Beginning July 1, 2021, Express Scripts, Inc.®´, an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the National Preferred Formulary. Included in this update are medications that will no longer be covered under the National Preferred Formulary.
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, Express Scripts has removed medications from their formulary. However, a doctor may request an exception if these medications are medically necessary. If the exception is approved by Blue Cross, you’ll pay the highest-tier cost.
Upcoming Coverage Changes for Certain Medications Moving from Our Medical to Pharmacy Benefit
Effective July 1, 2021, coverage for the following medications will move out of our medical benefit and only be included under our pharmacy benefit. This change will apply to all medical plans, except Managed Blue for Seniors, group Medicare Advantage, group Medex®´, and Federal Employee Program plans.
Medications Moving from Our Medical to Pharmacy Benefit
Available at Retail Pharmacies
Durolane*
Gel-One*
GelSyn-3*
Monovisc*
Triluron*
Trivisc*
Must Be Filled at a Specialty Pharmacy
Bynfezia
Cosentyx*
Dupixent*
Fasenra*
Kevzara*
Nucala*
Siliq*
Strensiq
Tegsedi*
Tremfya*
Members who have plans with the Blue Cross Blue Shield of Massachusetts formulary, as well as Medex®’ plans** with a three-tier pharmacy benefit, or the National Preferred Formulary*** will receive coverage for these medications under their pharmacy benefit upon the effective date. Members with these plans will not experience a break in coverage as these medications move from the medical benefit to the pharmacy benefit. Group Medex plans with a three-tier pharmacy benefit will include coverage for these medications under both the medical and pharmacy benefit. If you don’t have pharmacy coverage from Blue Cross Blue Shield of Massachusetts, refer to your pharmacy plan benefit materials for coverage details on these medications.
If affected, we’ll contact you about this change and help you transition your prescription to support uninterrupted coverage.
This change doesn’t apply when these medications are administered in inpatient, surgical day care, ambulatory surgery center, and emergency department settings.
Questions?
For more information, call Team Blue at the Member Service number on your ID card.
*These medications require prior authorization.
**This doesn’t include Medex 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
***Plans with the National Preferred Formulary may have additional coverage requirements for these medications.
Changes to Our Specialty Pharmacy Network for Fertility Medications
Beginning August 31, 2020, AcariaHealth™ Fertility will no longer participate in our specialty pharmacy network for fertility medications. This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the National Preferred Formulary (NPF).
Members will be able to complete their current course of treatment with AcariaHealth Fertility; however, specialty fertility medications purchased through AcariaHealth Fertility after August 31, 2020, will no longer be covered. We’ll contact members who fill their prescriptions at AcariaHealth Fertility to let them know that the pharmacy is leaving our specialty fertility network, and help them transition to another in-network specialty pharmacy for fertility medications. This change only applies to AcariaHealth Fertility and our specialty fertility network. AcariaHealth Fertility’s parent company, AcariaHealth, will remain in our specialty pharmacy network.
Specialty pharmacies provide specialty medications that are used to treat certain complex health conditions. For more information about specialty medications, use our Medication Lookup tool.
If you have any questions, please call Member Service at the number on the front of your ID card.
Coverage Update for Truvada
On July 1, 2020, we’ll begin covering Truvada, an HIV pre-exposure prophylaxis (PrEP) medication, at no additional cost for members who aren’t currently filling other HIV medications. Members taking other HIV medications, or are switching from an HIV medication to Truvada, will have to pay their usual out-of-pocket costs, including copays, co-insurance, and deductibles. This change applies to new prescriptions and refills, and to plans with either the Blue Cross Blue Shield of Massachusetts Formulary or National Preferred Formulary. However, the change doesn’t apply to grandfathered plans that don’t comply with the Affordable Care Act.
When the generic version of Truvada is released, we’ll start covering the generic version (instead of Truvada) at no additional cost for members who aren’t currently filling other HIV medications. At that time, members who continue to take Truvada, whether they’re taking additional HIV medications or not, will have to pay their usual out-of-pocket costs, including copays, co-insurance, and deductibles.
If you have any questions, please call Member Service at the number on the front of your ID card.
Coverage Change for Breast Cancer Risk-Reduction Medications
On October 1, 2020, we’ll begin covering the following generic oral medications in the class of aromatase inhibitors at no additional cost for members when the medications are prescribed to reduce breast cancer risk:
Anastrozole
Exemestane
Letrozole
This change applies to plans with either the Blue Cross Blue Shield of Massachusetts Formulary or the National Preferred Formulary. However, this change doesn’t apply to grandfathered plans that don’t comply with the Affordable Care Act.
If you have any questions, please call Member Service at the number on the front of your ID card.
Changes to our speciality pharmacy network
Beginning March 31, 2020, BriovaRx®'' will no longer participate in our specialty pharmacy network. This change applies to the Blue Cross Blue Shield of Massachusetts formulary, and the National Preferred Formulary (NPF). This doesn't affect members who have Medicare Advantage with a Part D prescription drug plan; they can continue to use BriovaRx without interruption.
Unless you have Medicare Advantage with a Part D plan, you’ll no longer be covered for specialty medications purchased through BriovaRx. We’ll contact members who fill their prescriptions at BriovaRx to let them know that the pharmacy has left our network, and help them transition to an in-network specialty pharmacy.
Specialty pharmacies provide specialty medications that are used to treat certain complex health conditions. For more information about specialty medications, use the Medication Lookup tool.
If you have any questions, please call Member Service at the number on the front of your ID card.